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Developmental survival, axon growth and differentiation of sensory neurons are mediated 
through the actions of specific sets of transcriptional signaling complexes (Anderson, 1999). A 
newly recognized family of transcription factors that appear to have important roles in sensory 
neuron biology is the Sox family of high-mobility group (HMG) domain proteins. In a screen of 
transcriptional activity in transgenic animals that overexpress either NGF or GDNF in the skin 
(NGF-OE and GDNF-OE mice), the transcription factor Sox11 was significantly increased in 
developing neurons of the trigeminal ganglia. This increase suggests Sox11 expression is trophic 
factor sensitive and that it may contribute to the transcriptional control of genes involved in the 
increased survival and axonal projections that has been documented in these transgenic animals 
(Albers et al., 1994; Zwick et al., 2002). Sox11 was also increased in neurons of adult dorsal root 
ganglia (DRG) following sciatic nerve cut. The rise in Sox11 in response to enhanced trophic 
factor level and axotomy has led us to hypothesize that Sox11 is an essential transcriptional 
regulator in both embryonic and adult systems that is trophic factor responsive.  
 
To further investigate the role of Sox11 and begin to identify transcriptional targets, the 
level of Sox11 was assayed in the Neuro2A stem cell line (Klebe and Ruddle, 1969), primary 
dorsal root ganglion (DRG) neurons and in vivo after nerve injury. Upon retinoic acid (RA)- 
induced differentiation of Neuro-2A cells and upon culturing DRG neurons, Sox11 mRNA 
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increased, suggesting Sox11 was important for expression of genes involved in Neuro2A and 
primary DRG differentiation and survival. To test this, the level of Sox11 expression was 
knocked down in Neuro2A cells and cultured DRG neurons by transfection of siRNAs against 
Sox11. Knockdown of Sox11 in these cells caused cell death and inhibited axon growth.  RNAi 
knockdown of Sox11 in vivo after a saphenous nerve crush injury also inhibited axon 
regeneration.  These data suggest that the developmentally regulated transcription factor Sox11 
is induced in adult neurons after injury to promote neurite growth and axon regeneration and 
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1.0  INTRODUCTION 
1.1 NEUROTROPHINS REGULATE SENSORY NEURON DEVELOPMENT 
Neurotrophic growth factor proteins expressed in peripheral target tissues are essential 
for the survival of specific types of sensory neurons that innervate these tissues (Oppenheim, 
1991; Thoenen, 1987).  Two neurotrophic factors, nerve growth factor (NGF) and glial-cell line 
derived neurotrophic factor (GDNF) support the development of two distinct types of cutaneous 
nociceptor or pain transmitting neurons.  NGF produced in the skin binds and signals through the 
neuronally-expressed receptor tyrosine kinase (trk) A, whereas GDNF binds and signals through 
a complex containing the receptor tyrosine kinase Ret and a specific glycosyl-phosphatidyl 
inositol (GPI)-anchored member of the GDNF family receptors (GFRs) (Averill et al., 1995;  
Verge et al. 1995; Perl, 1996; Pachnis et al. 1993; Molliver et al. 1997; Bennett et al., 1998).  
NGF and GDNF-dependent nociceptors are thought to underlie transmission of different types of 
pain. NGF responsive, trkA positive neurons that express the neuropeptides substance P and 
calcitonin-gene related peptide (CGRP) are thought to mediate inflammatory pain signaling 
(McMahon 1996), whereas the peptide poor, isolectin B4-binding, GDNF responsive population 




It is well accepted that sensory neuron survival is dependent on the level of target-derived 
growth factors.  In addition, studies that increase or decrease growth factor signaling have 
suggested that they affect differentiation as well.  Mendell and coworkers (Lewin et al. 1992) 
found that the level of NGF altered the balance of c-fiber and D-hair innervation in the skin of 
the rat.  Treatment with anti-NGF decreased the number of c-fibers innervating the skin while 
simultaneously increasing the number of D-hairs.  The conclusion from these studies was that 
NGF was required for the maturation of c-fiber innervation. In another study, Stucky et al 
(Stucky et al. 1999) found that the heat sensitivity of c-fibers was increased four fold in mice 
overexpressing NGF, whereas Aδ high threshold mechanoreceptors were twice as sensitive to 
mechanical stimulation.  Mice lacking BDNF (a member of the neurotrophin family) exhibit a 
loss of mechanical sensitivity in slowly adapting myelinated fibers without affecting survival of 
these neurons (Carroll et al. 1998).  Finally, mice overexpressing NT-3 in skin exhibit non-
overlapping dermatomes, indicating significant changes in peripheral projections (Ritter et al. 
2001).   Taken together, these studies suggest that growth factors can play an important role in 
both survival and phenotypic differentiation of sensory neurons.  
  
During early development (E12), virtually all sensory neurons express trkA and up to 
80% continue to express trkA until late in development (ca. E18).  At E13, ret and GFRα1 begin 
to be expressed in sensory neurons and increase throughout embryonic development and 
postnatally (Baloh et al. 2000).  The expression of these receptors extends into the postnatal 
period when sensory neurons are differentiating.  Most importantly for nociceptors, these 
proteins are expressed at a time when a developmental switch from NGF to GDNF 
responsiveness occurs (Mu et al. 1993; Pachnis et al. 1993; Widenfalk et al. 1997; Jackman and 
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Fitzgerald 2000).  While CGRP and Ret expression increases into late prenatal and early 
postnatal stages, trkA expression declines around P0 (Mu et al. 1993; Bennett DL 1996; Molliver 
et al. 1997).  IB4 is not expressed embryonically, appears at birth and increases gradually over 
the first weeks of development (Bennett DL 1996; Molliver et al. 1997; Guo et al. 2001).  
 
The dynamic changes in neurotrophic growth factor and receptor expression that occur 
during development of NGF- and GDNF-dependent neurons suggests a high level of temporal 
and spatial regulation.  To examine this regulation and begin to identify genes that might regulate 
development of various sensory neuron populations, a transgenic mouse model system in which 
2.3Kb of the human K14 keratin promoter and enhancer drives expression of various 
neurotrophic factors in the skin was utilized. Overexpresser animals (OE mice) were used to 
establish the temporal expression patterns of phenotypic markers of NGF responsive and GDNF 
responsive nociceptive neurons to determine if a developmental shift in the expression of trkA, 
CGRP, Ret and IB4 occurs in animals in which excess trophic factors are present. The goal was 
to determine if trophic factor levels regulated the onset of neuronal phenotypic properties as 
defined by expression of peptides and receptors.  Various embryonic and postnatal stages of 
development were compared to adult patterns.  It was found that overexpression of trophic 
factors in the periphery did not accelerate expression of phenotypic markers but did result in a 
change in the distribution of these markers in each transgenic line (Fig.1).  No effect was seen at 
E16.5 or P2 (not shown) although a differential distribution of markers for the subtypes of 
neurons in the transgenic animals was detected by P8.  Mice that overexpress GDNF (GDNF-
OEs) had an increase in the percentage of ret-positive cells and a decrease in the percentage of 










Fig. 1:  Light micrographs of trigeminal ganglia (TG) immunoreactive for trkA, CGRP or c-Ret 
or stained for IB4 at postnatal day 8 in wild type, GDNF-OEs or NGF-OEs.  Unlike P2 animals, 
P8 TGs show an increase in trkA and CGRP positive neurons in the NGF-OE animals and an 
increase in the number of c-Ret positive cells in both NGF-OE and GDNF-OE animals.  
Preliminary cell counts show a decrease in the number of IB4 neurons at P8 when overproducing 
NGF while GDNF overproduction results in a decrease in the number of trkA neurons.   
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immunopositive for CGRP and trkA and a subsequent decrease in the percent of cells that bind 
IB4.  These preliminary findings suggested that phenotypic switching between NGF-dependence 
and GDNF-dependence occurs postnatally (by P8).  
 
Having established that enhanced levels of skin-derived trophic factors did not accelerate 
differentiation but rather enhanced the size of the responsive population, experiments were 
designed to identify how these changes were occurring via neurotrophic regulation, ie. what were 
the downstream mediators of neuronal development?  A large scale genomic screen using 
Affymetrix gene chips was used to identify transcripts specific to neuron subpopulations. 
Affymetrix-based analysis of RNA expression using RNA from trigeminal ganglia of embryonic 
day 16.5 and adult sensory ganglia from GDNF- and NGF-OE mice exhibited several changes in 
gene expression (Table 1).  Classes of genes that showed change that were of particular interest 
were phosphatases, γ-amino-butyric acid (GABA) receptors and transcription factors.   It is 
feasible to hypothesize that changes in these types of genes would underlie at least some of the 
anatomical, electrophysiological and behavioral changes characterized in the GDNF and NGF-
OEs.   
 
Phosphatase expression analysis.  Neuronal phosphatases have been associated with control of 
neuronal differentiation, axon pathfinding and survival (Stroker and Dutta, 1998).  These 
proteins have been linked to regulation of cytoskeletal function (Sanchez et al., 2000) and 
neurotrophin mediated cell survival and neurite growth (Tisi et al., 2000).  Affymetrix analysis 
showed transcript levels of two phosphatases, the dual specificity phosphatase 6 (DUSP6) and  
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Table 1:  Microarray analysis of trigeminal ganglia from animals that overexpress either nerve 
growth factor or glial cell line-derived neurotrophic factor in the skin at embryonic day 16.5 and 






















protein tyrosine phosphatase receptor type O (PTPro), were increased in adult sensory ganglia of 
NGF- and GDNF-OE transgenic mice. Reverse transcriptase PCR (RT-PCR) analysis of RNA  
isolated from sensory ganglia confirmed this increase in expression.  GDNF overproduction 
resulted in a greater increase in DUSP6 than NGF overproduction (1.8-fold vs. 1.62-fold, 
respectively) while NGF-OEs caused a larger increase in PTPro in TG compared to GDNF-OEs 
(1.64-fold vs 1.44-fold respectively) when compared to adult wild type animals (n=1).  PTPRo 
has been associated with axon outgrowth and differentiation of sensory neurons (Beltran et al. 
2003).  It is expressed by trkA and trkC neurons of developing DRGs and may enhance motor 
neuron outgrowth (Stepanek et al. 2005).  The role of DUSP6 is less clear but is thought to have 
the ability to dephosphorylate extracellular signal related kinase (ERK) 2, one of the major 
mitogen activated protein kinases (MAPKs) (Castelli et a., 2004; Furukawa et al., 2006).  It may 
have a role in axial patterning through regulation of fibroblast growth factor 8 (FGF 8) signaling 
(Echevarria et al. 2005; Tsang et al. 2006), but also has been linked to the development of 
psychiatric disorders that include schizophrenia and bipolar disorder (Lee et al. 2006).  The 
increased expression of these phosphatases in sensory neurons exposed to enhanced levels of 
growth factors may reflect a means by which control can be exerted over the activation of growth 
factor signaling pathways in neurons. 
 
GABA receptor expression. GABA receptor activation is known to be critical for the 
development of sensory neuron function (Vinay et al., 1999).  RT-PCR quantification of GABA 
A receptor subunit α3 and γ2 in postnatal animals overexpressing GDNF indicated a large down-
regulation of the GABA A α3 subunit in GDNF-OE trigeminal ganglia at P8 that returned to 
wildtype levels by P16.  The γ2 subunit of the GABA A receptor was unchanged in GDNF-OE 
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ganglia at P8 but upregulated by P16.  No change in the α1 or α2 subunits at either stage was 
detected when comparing GDNF-OEs to wild type animals (n=1; not shown).  Few studies have 
ascribed a function for the various GABA receptor subunits during the development of DRG 
neurons but individual subunit expression may play a role in synaptogenesis or cell type 
electrophysiological properties (Mitchell and Redburn, 1996) resulting in different sensory 
neuron phenotypes.   
 
Although changes in phosphatase and GABA receptors (and other genes listed in Table 
1) may underlie various aspects of the development and maturation of sensory neurons 
responsive to GDNF and NGF, we chose to focus analysis on transcription factors, specifically, 
the SRY-Box containing gene 11 or Sox 11, which was found to be elevated in ganglia of the 




1.2 SOX GENES ARE IMPORTANT REGULATORS OF DEVELOPMENT 
SRY-box containing gene 11 (Sox11) is a member of the group C high mobility group 
(HMG) transcription factor family (Azuma et al., 1999; Hargrave et al. 1997).  There are 
approximately 20 members of the Sox gene family which have been divided into 7 subgroups 
based on sequence homology within groups.  Sox proteins, as members of the HMG superfamily 
of DNA-binding proteins, may either activate or repress transcription of target genes. HMG 
proteins are characterized by an 80 amino acid DNA binding domain (the HMG box) that 
mediates binding to AT rich DNA sequences.  HMG box containing transcription factors are 
thought to interact with other components of the transcriptional machinery and the combination 
of these factors is thought to be cell type specific (Dailey and Basilico, 2001).  The HMG 
domain is highly conserved among Sox factors, all of which recognize a similar binding motif 
(WWCAAWG, where W is either an A or T).  However, a given cell type can co-express a 
number of Sox genes, suggesting interactions with other protein partners is required to provide 
specificity in directing a gene expression pattern for a particular cell type (Kamachi et al, 2000; 
Wilson and Koopman, 2002). 
   
The expression of many Sox genes has been shown to be regulated both spatially and 
temporally during development (Gubbay et al., 1990; Wright et al., 1993; Wilson and Koopman, 
2002) and all appear to influence various aspects of embryonic development.  For example, Sox8 
and Sox17 are linked to development of muscles tissues (Schmidt et al., 2003) and the endoderm 
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(Kanai-Azuma et al., 2002), respectively. During pancreatic development (Lioubinski et al., 
2003) and formation of the nervous system (Hargrave et al., 1997) several Sox genes are 
expressed that include Sox11.  Mutations in Sox genes have also been associated with human 
developmental disorders such as campmelic dysplasia (Sox9; Foster et al., 1994; Wagner et al., 
2002) and Waardenburg/Hirschsprung syndrome (Sox10; Herbarth et al., 1994; Kuhlbrodt et al., 
1998; Pingault et al., 1998).  High levels of Sox11 have also been found to be associated with 
human gliomas (Wiegle et al., 2001).   
 
Sox11 mRNA is expressed in developing mouse embryos as early as embryonic day 8.5 
(E8.5) (Hargrave et al., 1997). By northern hybridization, Sox11 expression was found to 
gradually increase up to day E13.5 and then decline beginning at E16.5.  In situ hybridization 
showed Sox11 expression localized to developing sensory ganglia including the trigeminal 
ganglion (TG) and dorsal root ganglia (DRGs) as well as the spinal cord (SC; Hargrave et al., 
1997). The localization and timing of upregulation suggests that Sox11 has a role in regulating 
transcription of genes important for neuronal survival and differentiation. Our preliminary data 
supports this notion in several ways. First, we detected a 2-4-fold increase in Sox11 expression 
in E16.5 trigeminal ganglia of NGF-OE and GDNF-OE transgenic animals (Fig.2).  This 
increase in expression correlates with the enhancement in neuron survival and axonal projections 
exhibited by NGF-OE and GDNF-OE mice (Albers et al., 1994; 1996; Figueiredo et al. 1999; 
Zwick et al., 2002).  Anti-Sox11 antibody labeling of E14.5 trigeminal ganglia showed that the 












Fig. 2: A. Reverse transcriptase (RT)-PCR verification of gene chip data in pooled trigeminal 
ganglia isolated from E16.5 mice.  Relative to WT mice, GDNF-OE mice had a 2.8-fold increase 
while NGF-OE mice had a 4.3-fold increase.  B. Confocal micrograph showing Sox11 
localization in neurons of E14.5 trigeminal ganglia. The white arrow indicates a neurofilament 
positive (green, cytoplasm) and Sox11 (red, nucleus) positive neuron. Most cells showed 
colocalization of Sox11 and NF150, though some appeared Sox11 negative (yellow arrow).  
Neuronal expression was also evident at E16.5 (not shown). 
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The increased expression of Sox11 in developing neurons of OE transgenic mice led us to 
hypothesize that Sox11 is a downstream regulator of survival and differentiation of sensory 
neurons in a neurotrophic factor dependent manner. To test this possibility the studies of this 
dissertation examined if the level of Sox11 modulated expression of genes involved in cell 
survival pathways or affected axon growth in models of differentiation and following neuron 
injury. Because changes in caspase activation and axon growth were used to assess Sox11 




1.3 CASPASE MEDIATED PROGRAMMED CELL DEATH 
Studies using BrdU and TUNEL labeling showed that the increased survival of neurons 
in NGF-overexpressing mice was due to a trophic factor–mediated block in apoptotic cell death 
in developing neurons rather than stimulation of neuronal precursor replication (Figueiredo et al. 
1999).  Apoptotic programmed cell death is widespread during neurogenesis when 
approximately 50% of born neurons die.  Apoptosis is generally thought to establish the 
appropriate number of neurons and innervation density of targets (Oppenheim, 1991).  
Programmed cell death can involve many biological pathways that collectively induce DNA 
fragmentation, chromatin condensation and membrane disruption and typically involve 
activation of caspase proteases (Hoshi et al., 1998; Nijhawan et al., 2000; Sakurai et al., 2003).  
Caspase-mediated apoptosis is regulated by both extrinsic and intrinsic mechanisms.  Activation 
of death receptors such as tumor necrosis factor (TNF) receptors, their co-receptors Traf 1-4 and 
Fas receptors (Boldin et al., 1995) activate initiator caspases such as caspase 8, a major regulator 
of the apoptosis effector caspases such as caspase3 (Boldin et al., 1996; Nijhawan et al., 2000; 
Muzio et al., 1996; Srinivasula et al., 1996).  Caspase 3 (and other effectors) activates many 
other proteins in the cytoplasm and nucleus involved in DNA fragmentation, actin 
destabilization, cell shrinkage and formation of apoptotic bodies (Thornberry and Lazebnik, 
1998). 
 
All caspases are activated by proteolysis with high specificity for cleavage after an 
aspartate residue.  Once activated, their initial function appears to be associated with cytoplasmic 
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inactivation of proteins that normally protect the cell from death and activation of proteins that 
disrupt the cell’s cytoskeleton.  For example, Bcl-2 proteins which are pro-survival 
mitochondrial membrane associated proteins that inhibit pro-apoptosis molecules like Bid, Bad 
and Bax are cleaved by caspases (Adams and Cory, 1998; Xue and Horvitz, 1998).  Effector 
caspases then begin to disrupt molecules that stabilize the cytoskeleton of the cell including those 
of the nuclear lamina (Thronberry and Lazebnik, 1998), gelosin (Kothakota et al., 1997), focal 
adhesion kinase (Wen et al, 1997) and p21 activated kinase 2 (Rudel and Bokoch, 1997).  Once 
the cell structure is compromised, caspases can then translocate to the nucleus (Kamada et al., 
2004; Ramuz et al., 2002) to activate DNA fragmentation factors and inhibit DNA repair 
enzymes (Thornberry and Lazebnik, 1998).   
 
Caspases themselves are also regulated by inhibitory enzymes, mainly the inhibitors of 
apoptosis (IAP) family such as xIAP.  IAPs control apoptosis, possibly through direct inhibition 
of effector caspases (Deveraux et al., 1997).  Effector enzymes are thought to be a part of a 
positive feedback loop in that these caspases can activate other effectors of the cascade.  IAPs 
inhibit the effector activation and thus appear to function as negative regulators of this feedback.  
It has also been hypothesized that the IAPs also control the cellular localization and 
concentration of caspases furthering their role in apoptosis regulation (Thornberry and Lazebnik, 
1998).  More work on how IAPs and other inhibitors regulate caspase function will be necessary 
to fully understand how caspases regulate apoptosis; however, current knowledge does show that 
caspases are major regulators of programmed cell death and are an important feature of normal 
neuronal development.  Determining how these pathways are activated by Sox11 was 
investigated in these studies.   
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1.4 AXON OUTGROWTH AND NERVE REGENERATION 
A major goal in neuroscience is to understand the cellular processes that underlie 
functional regeneration of neurons in both the peripheral and central nervous system. 
Regeneration in the PNS is known to occur in many cases following injury whereas regeneration 
in the CNS does not.  Differences between regenerating peripheral and central axons appear to 
lie in the presence of inhibitory enzymes in the CNS (Kury et al., 2001; Qiu et al., 2001). In 
addition, transcriptional mechanisms thought to allow recovery in the PNS are not induced in the 
CNS (Kenny and Koscis, 1997).  For example, activating transcription factor 3 (ATF3) is 
induced in DRG neurons after sciatic nerve axotomy but not after L4 rhizotomy (Shortland et al., 
2006).   
After injury to a nerve, a period of “dying back” from the site of injury followed by the 
initiation of anterograde degeneration (Wallerian Degeneration) occurs during the first several 
days (Baba et al., 1982; Mi et al., 2005; Sebille, 1982; Thomas, 1982).  Wallerian Degeneration 
(WD) is a normal phenomenon that occurs upon injury that serves to degenerate the injured 
axons and in so doing, clear a path for axon to regenerate.  Features associated with WD include 
inflammatory cell infiltration, glial cell proliferation and ubiquitination.   
 
Injury to a nerve almost always induces inflammation.  Within two days, T cells and 
macrophages infiltrate and clear myelin debris at the injury site (Bruck et al., 1997; Jander, 2001; 
Perry et al., 1987; Stoll et al., 1989; Stoll and Janner, 1999) and through the distal stump which 
 17 
is the main source of inhibitory enzymes that block regeneration (Qiu et al., 2000).  Upregulation 
of inflammatory cytokines like IL-1β, IL-6 and IL-10 occurs within 24h of injury and helps to 
facilitate the inflammatory response (Bolin et al., 1995; Bourde et al., 1996; Gillen et al., 1999).  
Proteins such as TNF-α also appear to be major factors in inducing inflammation (Liefner et al., 
2000).  In the CNS however, the inflammatory response appears to be localized to the injury site 
only, and may be a major reason why long range axon regeneration does not readily occur 
(George and Griffin, 1994; Perry et al., 1987).   
 
Nerve injury disrupts normal Schwann cell (SwC) association with axons which leads to 
proliferation and expression of pro-regeneration genes such as N-myc downstream regulated 
gene 1, which is thought to facilitate SwC to axon signaling (Kury et al., 2001).  Once signaling 
is re-established between neurons and SwCs, other factors such as ninjurin 1 are upregulated and 
promote growth cone outgrowth (Araki and Milbrandt, 1996).  Neurotrophins and their receptors 
are also induced after nerve injury and their expression by SwCs is thought to promote neuron 
survival and neurite extension (Paratcha et al., 2001).  Injuries to the nerve also cause rapid 
influx of calcium (Ca++), which promotes ubiquitination leading to targeted protein degradation 
of neurofilaments and microtubules (Ehlers, 2004).  This degeneration of the axon is necessary to 
promote clearing, macrophage phagocytosis of debris and SwC proliferation. 
 
Several genes that are upregulated following nerve injury may have a role in peripheral 
nerve regeneration in adult mice.  Small proline rich protein 1a, Sprr1a, has been shown to 
promote neurite outgrowth of primary DRG neurons and enhance peripheral nerve regeneration 
(Bonilla et al., 2002).  Actin related protein complex subunit 3, Arpc3, has not been shown to be 
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associated with neurite outgrowth specifically, but it is known that Arpc3 is present at the site of 
active actin filament assembly (Welch et al., 1997) and necessary for actin filament branching 
(Volkmann et al., 2001) which occurs in growth cones.  ATF3 expression is not normally 
detected in adult DRG neurons, but is significantly upregulated following peripheral nerve 
axotomy (Campbell et al., 2003; Isacsson et al., 2005; Lindwall et al., 2004; Tsujino et al., 2000) 
and in cultured DRG neurons (Seijfers et al., 2006).  ATF3 is also known to be associated with 
neurite sprouting (Pearson et al., 2003).  Other developmentally regulated genes have also been 
shown to have a role in adult mice after peripheral nerve injury such as c-jun (Lindwall et al., 
2004; Pearson et al., 2003) and extracellular signal related protein kinase (ERK; Chierzi et al. 
2005; Doya et al., 2005; Obata et al. 2004).  These proteins may have a role in cytoskeletal 
reorganization in regenerating axons.   
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2.0  SIGNIFICANCE 
The long-range goal of the following studies was to determine how the Sox11 
transcription factor affects expression of genes involved in neuronal survival and differentiation 
and whether this transcription factor has a role in peripheral nerve regeneration.  Neurotrophins 
have a potent effect on neuronal development, and our analysis suggested that one of the possible 
downstream targets modulated by neurotrophic factor signaling is Sox11.  Our data indicate that 
Sox11 expression is essential for the survival and differentiation of neurons that are either 
chemically stimulated to differentiate or put under stress of axotomy and culture.  Experiments 
using the neuroblastoma cell line, Neuro2A, show that differentiation of these cells requires 
expression of Sox11.  If Sox11 expression is reduced at the time these cells undergo 
differentiation, they enter an apoptotic death pathway and do not project neurites.  Thus, Sox11 
potentially regulates genes associated with neuronal survival and differentiation.   
 
Sox11 mRNA was also found to be elevated in developing sensory neurons in response to 
increased levels of trophic factors.  Its putative role in regulating differentiation of Neuro2A cells 
suggests it has a central role in regulating genes involved in neuron differentiation.  That Sox11 
expression is elevated in response to trophic factors also suggests it may be activated in response 
to injury, which is a known stimulus of trophic factor mediated gene expression in the adult. We 
therefore also performed experiments to determine the role of Sox11 in adult sensory neurons in 
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vitro and following injury in vivo.  Based on evidence that shows Sox11 is upregulated in adult 
primary DRG cultures and in neurons after axotomy, it is possible that Sox11 is part of a 
transcriptional program utilized during development that is revisited in the adult PNS in response 
to injury (Aubert et al., 1995).  The data outlined herein provides the first information on the role 
of Sox11 in neuronal survival and nerve regeneration and identifies possible targets of its 
regulatory action.  These studies form the foundation of future studies that will allow us to 
perhaps understand on a transcriptional level, why peripheral neurons regenerate without 




3.0  SOX11 TRANSCRIPTION FACTOR IS REQUIRED FOR SURVIVAL AND 
DIFFERENTIATION OF NEUROBLASTOMA CELLS 
3.1 INTRODUCTION 
Members of the SRY box-containing (Sox) family of transcription factors are emerging 
as important transcriptional regulators whose activity underlies the development and 
differentiation of multiple organ systems. Twenty Sox genes have been identified in the mouse 
and human genomes and all contain a DNA-binding high mobility group (HMG) domain and 
protein specific domains implicated in activation and repression of gene transcription (Kamachi 
et al., 2000; Schepers et al., 2002). Several Sox genes are highly expressed in the developing 
central and peripheral nervous system and appear to regulate differentiation and cell fate in cell 
type specific manners. In mouse, Sox10 is expressed in neural crest precursors and has a role in 
establishing glial cell populations (Paratore et al., 2001). Sox 1, 2 and 3 are expressed in spinal 
neurons of developing chick embryos and downregulation of these factors is requisite for 
expression of the neuronal markers NeuroM, NeuN and Tuj1, suggesting an important role in 
regulating commitment to the neuronal phenotype (Bylund et al., 2003). In in vitro models, 
Sox6, which is also expressed in developing brain, was found to be essential for differentiation 
and neurite outgrowth of the embryonic carcinoma (EC) cell line P19 following retinoic acid 
(RA) stimulation (Hamada-Kanazawa et al., 2004). Sox6 was also critical for survival of RA-
stimulated P19 cells as evidenced by the increased apoptotic death that ensued upon inhibition of 
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Sox6 expression. In human EC cells similarly induced to differentiate into a neuronal phenotype 
with RA, Sox3 expression was up-regulated as Sox2 expression declined, suggesting regulatory 
roles for Sox2 and Sox3 in EC differentiation (Stevanovic, 2003).  
In the peripheral nervous system, the Sox11 transcription factor has been of interest 
because of its high level of expression in developing trigeminal and dorsal root ganglia (DRG) 
(Uwanogho et al., 1995; Hargrave et al., 1997) and potential role in the development of gliomas 
(Weigle et al., 2005). In sensory neurons the high level of embryonic Sox11 expression is 
markedly reduced at birth (Hargrave et al., 1997; Tanabe et al., 2003; Jankowski et al., 2004), 
suggesting tight control of its transcriptional activity. Towards identification of the targets and 
mechanism of Sox11 action, mice that lack a functional Sox11 gene were recently isolated (Sock 
et al., 2004). Newborn Sox11-/- mice exhibited widespread developmental abnormalities in the 
heart, lung, stomach, pancreas and skeletal systems and died soon after birth due to the severe 
defects in organ development. How knockout of Sox11 affected sensory neuron survival is still 
unclear, although neonatal Sox-/- mice did respond to tactile stimuli suggesting that at least some 
sensory neurons were present. 
We and others have found that Sox11 transcription is markedly elevated in adult sensory 
neurons following nerve cut injury (Tanabe et al., 2003; Jankowski et al., 2004). Sox11 therefore 
appears to have a role in developing neuron growth and survival as well as recovery of adult 
neurons following injury. To better understand the role of Sox11 and the genes it may modulate, 
we examined its function in regulating differentiation and survival in the mouse neuroblastoma 
cell line Neuro2a model system. Neuro2a cells can be induced to differentiate into a neuronal 
phenotype by exposure to retinoic acid (RA), a potent modulator of neurogenesis, neuronal 
specification and axonal outgrowth (Shea et al., 1985; Maden, 2001). Based on the high level of 
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Sox11 expression in developing sensory neurons, we hypothesized that Sox11 would have a role 
in regulating RA-induced differentiation in the Neuro2a model as well. Using siRNA-mediated 
knockdown, we asked if Sox11 was essential for survival and neurite extension following RA-
induced differentiation. Results indicate that Sox11 is important for RA-induced differentiation, 





















3.2 MATERIALS AND METHODS 
Cell culture.  The mouse neuroblastoma cell line Neuro2a (ATCC clone number CCL-131, 
Manassas, VA) (Olmsted et al., 1970) was maintained in Eagle’s minimal essential medium 
(MEM) containing 10% fetal bovine serum (MEMS) and 1% penicillin/streptomycin in an 
incubator set at 37oC and 5% CO2. Cells used were passaged no more than three times. For all 
experiments, cells were plated into 12- or 24-well plates at a concentration of 10,000 and 5,000 
cells/ well, respectively, or plated into 2- or 4-well chamber slides. Cells were grown in MEMS 
to 50% confluence (18-24h) and then treated with 20µM retinoic acid (RA, Sigma, St. Louis, 
MO), siRNAs or both depending on the experiment. The time of RA addition was considered the 
0h timepoint. Cells were incubated according to experimental design and at appropriate times 
RNA was isolated or cultures were fixed for immunocytochemistry. Experiments to determine 
the effect of siRNA treatment at various times after RA addition were done by setting up cultures 
as described above and then adding siRNA at various times (0h, 6h, 12h or 24h) after RA 
addition. Transfected cultures were harvested for RNA or morphological analysis at 24h after 
siRNA addition. 
siRNA treatment. Two hours prior to siRNA transfection fresh medium was added to cultures. 
Cells were then treated with either 20µm RA alone or in combination with 10nM Sox11 siRNAs 
or 10nM non-targeting siRNAs (Dharmacon, Lafayette, CO). For transfection, TRANSIT-TKO 
transfection reagent (Mirus Corporation) was used. 2-4µl of the tranfection reagent was added to 
50 or 100µl of serum-free MEM, respectively. The solution was mixed, incubated at room 
temperature (RT) for 5-20 min. and the appropriate volume of 1µm siRNAs added to obtain a 
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final concentration of 10nM siRNA per culture well. Solutions were further mixed by pipetting, 
incubated at RT for 5-20 min and then added to the cultures. 
Cell counting, morphology and differentiation measures. Cells grown on chamber slides were 
fixed 5 min with 4% paraformaldehyde, washed with phosphate buffered saline (PBS) and 
coverslipped with glycerol for light microscopic analysis on an Olympus BH-2 miscroscope 
equipped with a differential interference contrast filter.  Differentiated cells were quantified 
using criteria similar to those described in Munch et al (2003). Cells with at least two neurites 
extending from the soma or one neurite longer than the diameter of the soma were considered 
differentiated. Cells undergoing apoptosis were identified by shrunken cell membranes, reduced 
size or disrupted nuclei (Hoshi et al., 1998; Sakurai et al., 2003). Cells are reported as a percent 
of total cells counted within gridlines of 4 randomly selected squares each 600 µm2 using a 
photoetched gridded coverslip (Electron Microscopy Sciences, Hatfield, Pa) at 10x magnification 
(n=3 per condition). The percent of cleaved caspase 3(casp3*)-labeled cells was calculated by 
counting the number of casp3* positive cells in 4 randomly selected fields equal to the size of the 
photoetched grids used for morphological quantification. For each condition, n equaled 3. 
Statistical significance between conditions was determined by p-values < 0.05. 
Cell immunolabeling. After fixation and rinsing, cells were blocked in 0.25% triton X-100 with 
5% normal goat serum in PBS for 30 min. and incubated in either goat anti-Sox11 (1:100; Santa 
Cruz Biotech, Santa Cruz, CA) or rabbit anti-casp3* (1:100; Cell Signaling Technologies, 
Danvers, MA) overnight at room temperature. Cells were washed in PBS and incubated 2h in 
1:500 dilutions of FITC-conjugated donkey anti-rabbit antibody or CY2-conjugated donkey anti-
goat (Jackson, West Grove, Pa).  Slides were rinsed in PBS, coverslipped in glycerol and images 
captured using a Leica fluorescence microscope. 
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RNA isolation and reverse transcriptase-polymerase chain reaction (RT-PCR) analysis. Culture 
medium from triplicate cultures was removed and plates were washed 3 times with PBS. Cells 
were lysed with RLT buffer (Qiagen) with beta-mercaptoethanol and RNA isolated using the 
Qiagen RNeasy protocol for animal cells.  After RNA isolation, samples were treated with 
DNase I (Invitrogen) for 15 min at RT and 1 µg of DNased RNA reverse transcribed using 
Superscript II Reverse Transcriptase according to the manufacturer’s protocol (Invitrogen). 
Samples were stored at -80oC until used in PCR reactions.  For realtime PCR, samples of cDNA 
were added to a SYBR Green MasterMix (Applied Biosystems), run in triplicate on an Applied 
Biosystems Imager. Ct values (threshold cycles) were normalized to GAPDH by subtracting the 
target gene from the GAPDH control. A ∆∆Ct value was then calculated by subtracting the 
normalized experimental Ct from the normalized control condition with fold change reported as 
2∆∆Ct.   
SuperArray filter hybridization. Focused DNA microarray filters (GEArray Q Series Mouse 
Apoptosis Gene Array; MM-002) were used to identify genes involved in cell survival and death 
that may be regulated by Sox11. Parallel cultures were treated with 20µM RA in combination 
with either 10nM Sox11 siRNAs or 10nM non-targeting siRNAs. Total RNA (3µg) was isolated 
at either 12h or 24h post siRNA addition using the Qiagen RNeasy Mini-Kit protocol. RNA was 
reverse transcribed into 32P-dCTP-labeled probes according to the manufacturer’s protocol and 
annealed with primers at 70oC for 3 min followed by incubation at 37oC for 10 min.  A cocktail 
containing RNase inhibitors and reverse transcriptase was added to the annealing reactions at 
equal volume and incubated at 37oC for 25 min.  RNA was hydrolyzed at 85oC for five min, 
reactions were placed on ice, and then linear polymerase reactions containing primers specific to 
the apoptosis superarray were performed using 32P-dCTP spiked reactions according to PCR 
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parameters provided. Probes were denatured at 94oC for 2 min prior to hybridization.  Filters 
were prehybridized 2 h at 60oC in GEAHyb (Superarray) solution containing 100µg/ml sheared 
salmon sperm DNA (GEAPrehyb). Denatured probe in 0.75mL of GEAprehyb solution was 
incubated with filters overnight at 60oC with gentle agitation (5-10 rpm). Filters were washed 
twice in 2X SSC, 1% SDS at 60oC for 15 min with agitation, twice in 0.1X SSC, 0.5% SDS at 
60oC for 15 min. and then covered with plastic wrap and exposed to a phosphoimaging screen 
for an empirically determined amount of time. Phosphoimaging screens were read on a BioRad 
phosphoimager and values obtained by subtracting filter background intensity and normalizing to 
GAPDH controls on the filter.   
 
Statistics:  Statistical analysis was determined using Student’s t-test with p values < 0.05 as 
















3.3.1 SOX11 IS EXPRESSED IN NEURO2A CELLS.  
Neuro2a cells provide an excellent model system to study the role of Sox11 in 
transcriptional regulation of neuronal differentiation. They are easily propagated, they can be 
stimulated to differentiate by addition of 20µM retinoic acid (RA) and upon differentiation stop 
dividing and extend neurites (Shea et al., 1985; Sajithlal et al., 2002; Munch et al., 2003; 
Noguchi et al., 2003). Under normal culture conditions without RA, Neuro2a cells appear as 
amoeboid neuroblasts that begin to extend neurites after 1-3d in culture. To assess if Sox11 
might have a role in regulating genes important for this transition to the differentiated state, we 
assayed Sox11 mRNA levels at times prior to and coinciding with the initiation of neurite growth 
(6h, 1d, 2d and 3d post-plating). Reverse transcriptase-PCR (RT-PCR) assays showed that 
replicating cells with minimal neurite outgrowth had a relatively low level of Sox11 mRNA (Fig. 
3A, also see Fig. 6A). At 1d and 2d post-plating, a steady increase in Sox11 mRNA was found 
that correlated with an increasing number of neurite containing cells (Fig. 3B). By 3d in culture, 
Sox11 had increased 280% relative to the 6h timepoint level. Thus, a steady increase in Sox11 









Fig. 3:  A. Fold change in Sox11 mRNA in Neuro2a cells grown with or without 20µM retinoic 
acid (RA).  Sox11 expression increases gradually in cultures without RA (solid line).  Addition 
of RA caused early stimulation of Sox11 expression with a significant rise seen at 24 h after cell 
plating (dashed line).  Sox11 abundance was equivalent in the two culture conditions at 72 h.  N= 
3 at each point; p-value <0.001. B. Treatment with Sox11 siRNAs reduces Sox11 mRNA level in 
Neuro2a cells. Assay was done 24h after addition of a Smart pool siRNAs made against Sox11. 
Reduction in Sox11 occurs in a dose dependent manner. Asterisk indicates significant change, p< 
0.001. Levels are normalized to transfection reagent alone. C. Untreated Neuro2a cells show 
nuclear immunoreactivity for Sox11 protein. D. Sox11 siRNA treated Neuro2a cells lack nuclear 











It has previously been shown that Neuro2a cells undergo accelerated differentiation when 
grown in medium containing 20µM retinoic acid (MEMS-RA) (Shea et al., 1985). To determine 
if Sox11 has a role in this RA-induced differentiation, cells were treated with RA and the level of 
Sox11 mRNA measured (Fig. 3A). Neuro2a cells grown in MEMS-RA showed a 100% increase 
in Sox11 mRNA at 1d, in comparison with the 30% increase in cells grown without RA (Fig. 
3A). Sox11 expression continued to increase in RA medium and was increased 250% at 3d, a 
value not significantly different from that measured in cultures grown without RA. The transient 
increase in Sox11 mRNA in 1 d-old RA-treated cultures versus untreated cultures suggested 
Sox11 has a role in Neuro2a differentiation, particularly during early stages. 
 
3.3.2 siRNA-mediated knockdown of Sox11 occurs on translational and transcriptional 
levels. 
To test the role of Sox11 in Neuro2a differentiation, we reduced the cellular level of 
Sox11 by transfecting cells with a SmartPool of small interfering RNAs (siRNAs) targeted to 
Sox11. To insure a high transfection efficiency occurred in these cultures, cotransfections of 
Sox11 siRNAs and CY3-conjugated nontargeting siRNAs were done. Immunofluorescent 
analysis of transfected cultures showed nearly all (93%) cells were transfected (not shown). We 
then confirmed Sox11 knockdown on the transcriptional level using RT-PCR assays. 
Knockdown occurred in a dose dependent manner (Fig. 3B) with 10nM siRNAs producing a 
maximal 98% knockdown in Sox11 mRNA.  Several other non-targeting control experiments 
and RT-PCR analysis of other genes verified the specificity of the Sox11 knockdown (Fig. 4). 
Translational level knockdown of Sox11 was also confirmed using Sox11 antibody  
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Fig. 4: Control reactions for siRNA knockdown of Sox11 in Neuro2A cells. A. Untreated and 
non-targeting siRNA transfected cells both have similarly increased levels of Sox11 within 24h.  
B. Transfection of several other control siRNAs directed at non-Sox11 targets did not change 
Sox11 mRNA levels and did not affect Neuro2A survival.  C. Sox11 targeting siRNAs 
specifically knock down the expression of Sox11 and not other transcription factors of similar 
sequence homology like Sox9.  
 
 33 
immunolabeling of transfected cells. In untransfected cultures or ones transfected with non-
targeting siRNAs, Sox11-positive cells were easily detected (Fig. 3C). In contrast, Sox11-
positive cells were clearly reduced in cultures transfected with Sox11 siRNA (Fig. 3D).  
 
3.3.3 Increased expression of Sox11 is required for survival and neurite growth following 
RA-stimulation. 
 
To determine if Sox11 was required for RA-induced differentiation and neurite 
outgrowth, Neuro2a cells were treated with a combination of RA and Sox11 siRNAs.  As shown 
in Fig. 3B, cultures grown 24h with RA had a two-fold increase in Sox11 mRNA. With co-
addition of Sox11 siRNAs however, RA-treated cultures showed a 59% decrease in Sox11 
mRNA by 12h that was maintained out to 24h post RA/siRNA treatment (Fig. 5).  Knockdown 
of Sox11 in RA-treated cultures caused morphological changes as well. Compared to RA-only 
(Fig. 6B) and siRNA-only (Fig. 6C) cells, cells treated with RA plus Sox11 siRNAs had fewer 
neurites, many were shrunken and some appeared vacuolated and dying (Fig. 6D). To quantify 
these morphological changes, we determined the percent of differentiating cells with neurites, the 
percent of cells exhibiting features of apoptotic cell death (shrunken cell membranes, reduced 
size, disrupted nuclei) and the percent of activated caspase 3 (casp3*) immunolabeled cells (Fig. 
6, 7). In cultures grown for 24h in RA-only, less than 5% of the population had morphological 
features of apoptotic cells or were casp3*-positive (Fig. 7). Differentiating cells with neurite 
extensions were prominent and comprised 22% of the population. In contrast, only 8% of cells in 









Fig 5:  Percent change in Sox11 expression in Neuro2a cells cotreated with RA and Sox11 
siRNAs. Transfection of 10nM Sox11 siRNAs blocked the RA-induced increase in Sox11 
mRNA within 12h of addition. Knockdown was maintained for up to 24h at which time a 59% 
decrease was measured. N= 3 for each timepoint. Asterisk indicates p < 0.001 relative to 










Fig 6: Light micrographs of Neuro2a cells treated with RA and/or Sox11 siRNAs. A. Most 
Neuro2a cells grown in MEMS media for 24h show typical amoeboid morphology with few 
neurite projections. B. Cultures treated with RA for 24h contain more cells with extension of 
neuronal processes and evidence of differentiation.  C. Few cells in Neuro2a cultures treated for 
24h with siRNA against Sox11 show neurite projections and appear aggregated. D. Neuro2a 
cultures treated with RA and Sox11 siRNAs are clustered and many appear apoptotic (arrow). 
All images were taken at 24h post-treatment. 
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statistically unchanged relative to the percent of differentiated cells in untreated (no RA) 
cultures. In addition, cultures treated with RA plus Sox11 siRNAs had a significant increase in 
the percent of cells displaying apoptotic morphologies (18%) and casp3*-immunoreactivity 
(21%) (Fig. 6D, 7). Cultures treated with Sox11 siRNAs but not RA showed no difference 
compared to untreated cultures in the percent of differentiated cells, a small increase in the 
percent of apoptotic cells but no change in casp3*-positive cells (Fig. 7). Thus, a low degree of 
toxicity may result from RNAi treatment alone. To verify that the siRNA effects on cell death 
were specific to Sox11, we quantified the extent of differentiation and apoptosis in control 
siRNA transfected (siControl) and RA plus siControl treated cultures.  Addition of control 
siRNAs did not alter the level of cell death or differentiation in either condition relative to 
untreated or RA treated cultures (Fig. 7).  Taken together, this analysis shows that knockdown of 
Sox11 expression in RA-treated cultures inhibits RA-induced differentiation and neurite growth 
and significantly increases cell death.  
 
3.3.4 The ability to knockdown Sox11 in RA-treated cells is dependent on the time of 
transfection. 
To examine if the level of Sox11 is important for later stages of RA-induced differentiation, we 
attempted knockdown of Sox11 at various times after RA treatment. Cell cultures were treated 
with 20µm RA and Sox11 siRNAs were then added at 0h (as shown above), 6h, 12h or 24h post 
RA addition (Fig. 8). The level of Sox11 mRNA (Fig. 8E) and changes in morphology and 
casp3* (Fig. 8A-D, F) were then assessed. Unexpectedly, we found the level of Sox11 mRNA 
was only reduced in cultures in which siRNA transfection was done at the time of RA addition 
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(0h, Fig. 8E). No reduction of Sox11 mRNA was found in cultures transfected at 6h, 12h or 24h 
after RA addition. The morphology of cells transfected with Sox11 siRNAs 24h after RA 
addition was consistent with a lack of Sox11 knockdown, i.e., many cells had neurite extensions 
(Fig. 8B). Cells in parallel cultures transfected at the time of RA addition displayed few neurites 
and many had apoptotic morphologies (Fig. 8A), as previously observed (Fig. 6). Consistent with 
the prominent neurite growth in cultures transfected at 24h after RA addition, few if any casp3*-
labeled cells were visible (Fig. 8D) which again was in contrast to cultures transfected at the time 
of RA addition (Fig. 8C).  
Changes in morphology and apoptosis were then quantified across treatment groups in 
which siRNA was added at either 0h, 12h or 24h after RA (Fig. 8F). All measures were done at 
24h post siRNA addition. Cells treated concurrently with RA and siRNAs (0h timepoint) showed 
a percent of differentiated and casp3*-positive cells similar to previous assays (Fig. 7). However, 
in cultures in which Sox11 siRNAs were added at 6h (not shown) or 12h (Fig. 8F) after RA 
treatment, the percent of differentiated or casp3*-positive cells was unchanged from RA-only 
treated cells. For 12h cultures, 27% of cells showed a differentiated phenotype in both RA-only 
and RA plus siRNA groups and a very low percent of casp3*-positive cells. Similar results were 
found for cells treated with RA and transfected 24h later with siRNAs to Sox11 (Fig 8F). Co-
treated cultures had 38% differentiated cells, which is similar to the 42% percent of cells in the 
RA-only group. Thus, siRNA knockdown of Sox11 and its resulting effect on Neuro2a 













Fig. 7:  Combined treatment of RA and Sox11 siRNA enhances Neuro2a cell death. Chart shows 
quantification of differentiation (neurite growth) and apoptosis in cultures of Neuro2a cells 24h 
after treatment with RA alone, control (nontargeting) siRNA only, Sox11 siRNA only, RA plus 
control siRNA and RA plus Sox11 siRNA. Untreated cultures have few differentiating cells with 
neurites (black bar), few apoptotic cells (white bar) and virtually no cells immunopositive for 
activated caspase 3 (grey bar). RA-only treated cultures had a significant increase in the percent 
of differentiating cells whereas cultures with siRNA alone showed a slight rise in cells that were 
morphologically apoptotic. Neurite growth and apoptosis was not significantly different in 
cultures treated with control siRNAs.  Co-treatment with RA and control siRNA caused an 
increase in neurite containing cell, as expected.  Combination of RA and Sox11 siRNA reduced 
neuritre growth and caused a significant increase in the number of apoptotic cells and caspase3 
immunoreactivity. The number of cells analyzed for each group was as follows: untreated, 1,674 
cells; RA only, 1,275; Control siRNA only, 1,857; Sox siRNA only, 981; RA plus control 
siRNA, 1,398; RA plus Sox11 siRNA, 1,292. Values on chart are a percent of total cells 











Fig. 8: Sox11 expression is critical at the early phase of the transition of Neuro2A cells to a 
differentiated state. Differential interference contrast (DIC) images of Neuro2a cultures treated 
with Sox11 siRNAs at the time of retinoic acid (RA) treatment (0h) (A) and 24h after addition of 
RA (B). Note prevalence of cells with neurites in B but not A. C. Activated caspase 3(casp3*)-
labeling (arrows) appears in many cells co-treated with RA and Sox11 siRNAs at the 0h 
timepoint. D. Cells grown in RA for 24h and then treated with Sox11 siRNAs do not exhibit 
casp3* labeling. E. The reduction in Sox11 mRNA occurs only when Sox11 siRNAs are added 
simultaneously with RA. F. Plot of differentiating, apoptotic and casp3*-positive cells in cultures 
treated with RA and Sox siRNAs at various times after RA stimulation. Cultures in which RA 
and Sox11 siRNAs are added together (0h) have more casp3* positive cells (white box) and 
fewer differentiating cells (tan box) compared to RA-alone treated cells. Sox11 siRNA 
transfected at 12h or 24h after RA addition does not increase the number of casp3*-positive cells 
or decrease the number of differentiating cells normally seen following RA addition. All samples 
are n =3. The number of cells analyzed in each group was: At 0h, RA-only, 2351 cells; 
RA/siRNA, 2419 cells.  At 12h, RA-only, 2185 cells; RA/siRNA, 2061 cells.  At 24h, RA-only, 




3.3.5 Knockdown of Sox11 alters expression of genes associated with apoptosis. 
To identify how knockdown of Sox11 contributes to RA-induced Neuro2a cell death, we 
assayed gene levels following knockdown using tailored gene arrays spotted with cDNAs 
encoding genes linked to cell death pathways (Fig. 9). RNA isolated from Neuro2a cultures 
cotreated with RA or with a combination of RA and Sox11 siRNAs was analyzed at 12h or 24h 
after transfection. Analysis of gene arrays processed in parallel showed several genes were 
differentially expressed following Sox11 knockdown (Table 2). For several genes, the change in 
transcript abundance was different at 12h versus 24h post-transfection suggesting a dynamic 
change in gene expression at these times.  
 
It is difficult to know whether these changes in gene abundance are directly related to the 
reduction in Sox11 or whether they represent secondary effects of other transcriptional events. 
To address this issue and further validate some of the changes indicated by the gene arrays, four 
genes that contain 1-4 Sox factor HMG binding consensus domains (5’-(A/T)(A/T)CAA(A/T)G-
3’) within 1-2 Kb of their start codons, were further analyzed using real time RT-PCR assays 
(Fig. 9A,B). The genes chosen and results of this analysis are: 1) TRAF (TNF receptor-
associated factor) family member- associated NFkB activator (TANK) was decreased 31% at 
24h in the RA-Sox11 siRNA treated cultures, 2) Bcl2 interacting protein1, NIP3 (BNIP3), was 
increased 35% at 24h. 3) B lymphoid kinase (Blk) was statistically unchanged, though a trend 
toward increased expression was found and 4) B-cell lymphoma 2-like 10 (Bcl10), whose 












Fig. 9: Knockdown of Sox11 mRNA alters expression of genes involved in cell death pathways. 
RNA isolated from Neuro2a cells treated with RA or RA plus Sox11 siRNAs for either 12h or 
24h were analyzed using gene array filters. Plot shows RT-PCR analysis for 4 genes: Traf 
member and activator of NFkB (TANK), Bcl2-like 10 (Bcl10), B-lymphoid kinase (Blk) and 
Bcl2 interacting protein 1 NIP3 (BNIP3). All except Bcl10 were changed following knockdown 
of Sox11. All contain Sox transcription factor binding sites in their promoter regions. N=3 for 
each timepoint. Asterisk indicates p<0.05.  
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the accuracy of the gene array. The RT-PCR analysis of gene expression (Fig. 9), which was 
done in triplicate, was most consistent with the 24h timepoint array data listed in Table 1. This 
may reflect a more dynamic state in gene expression at the 12h timepoint. Together, these data 
suggest TANK and BNIP3 are targets of Sox11 transcriptional regulation and may have 
importance in mediating the RA-induced program of differentiation.  
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Table 2:  Change in mRNA level of apoptotic associated genes in RA-treated Neuro2a cells at 









Casp8ap2 NM_011997 Increased Increased 
Bnip3 NM_009760 Increased Increased 
Blk NM_007549 Decreased Increased 
Tank NM_011529 Increased Decreased 
Tnfrsf21 NM_178589 Increased Decreased 
Fas NM_007987 Decreased Decreased 
Casp2 NM_007610 Increased Decreased 
Casp3 NM_009810 Increased Decreased 
Casp9 NM_015733 Unchanged Decreased 
Bcl2a1d NM_007536 Increased Decreased 
Bok NM_016778 Increased Decreased 
Biklk NM_007546 Decreased Decreased 
Birc6 NM_007566 Decreased Decreased 
Mcl1  NM_008562 Decreased Decreased 




Table 2 Key: Casp8ap2, Casp8 associated protein 2; Bnip3, Bcl2/adenovirus E1B 19kDa-
interacting protein 1, NIP3; Blk, B lymphoid kinase; Tank, TRAF family member-associated 
NfkB activator; Tnfrsf21, TNF receptor superfamily, member 21; Fas, TNF receptor superfamily 
member; Casp2, Caspase 2; Casp3, Caspase 3; Casp9, Caspase 9; Bcl2a1d, B cell 
leukemia/lymphoma 2 related protein A1d; Bok, Bcl2 related ovarian killer protein; Biklk, Bcl2-
interacting killer-like; Birc6, Bacloviral IAP repeat-containing 6; Mcl1, Myeloid cell leukemia 





















We show in this study that the transcription factor Sox11 is normally expressed in the 
Neuro2A neuroblastoma cell line and that its expression is significantly increased as these cells 
differentiate into neuronal morphologies. Addition of retinoic acid stimulated expression of 
Sox11 at early phases of Neuro2A cell differentiation and reduction of Sox11 at this time caused 
a significant increase in apoptotic cells and blocked the normal RA-induced differentiation and 
neurite outgrowth typically expressed by Neuro2a cells. These changes only occurred if Sox11 
knockdown coincided with the time of RA addition, suggesting Sox11 has a crucial role in 
regulating early transcriptional events associated with the RA-induced commitment of Neuro2a 
cells to differentiation and survival pathways. Genes potentially involved in regulating cell 
survival that contain Sox11 binding sites in proximal upstream regulatory regions were also 
identified as possible targets of Sox11 activity. 
In cells grown without RA, Sox11 knockdown had little to no affect on either the number 
of differentiated or casp3*-positive cells present at 24h after siRNA treatment. In contrast, RA-
stimulated cells in which Sox11 was knocked down showed a significant decrease in 
differentiation (neurite growth) and increase in apoptotic morphology and casp3* 
immunoreactivity. That Sox11 knockdown in RA-treated cultures increased apoptosis suggests 
an essential role for Sox11 in regulating early transcriptional events induced by RA that promote 
entry into differentiation and survival pathways. A likely role for Sox11 is in regulation of genes 
involved in the RA response, which is transcriptionally mediated through RA binding to the 
nuclear retinoid receptors, RAR and RXR (Chambon, 1996; Mark et al., 2005). These ligand-
activated transcription factors act in conjunction with other transcription factors to stimulate and 
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inhibit gene expression. Sox11 therefore appears to be required for regulation of genes that 
facilitate the RA-induced cell differentiation and survival in neuroblastoma cells.  
The reduced number of differentiated cells and increased number of apoptotic cells that 
were found when RA and Sox11 siRNAs were added together (at 0hs) were not seen if siRNAs 
were added at 6h, 12h or 24h following RA stimulation. The level of Sox11 mRNA was 
unchanged as well. Why such a short window for effective Sox11 knockdown occurred in 
Neuro2a cultures is unclear. One possibility is that the increasing level of Sox11 mRNA that was 
induced by RA was too great to be effectively knocked-down by siRNA addition. Another 
possibility is that RA-induced differentiation altered the ability of Sox11 siRNAs to be processed 
efficiently in Neuro2A cells. The entry and processing of transfected siRNAs in RNA-induced 
silencing complexes (RISCs) may have changed following RA stimulation and as a result, 
inhibition of siRNA processing occurred. Precedence for inhibition of RISC activity is well 
documented in neuronal cells of Caenorhabditis elegans, which are refractory to RNA 
interference and resistant to siRNA modulation (Timmons, 2004). A similar mechanism of 
inhibition may underlie resistance to Sox11 RNAi modulation in Neuro2A cells that are RA-
induced to express a neuronal phenotype.  
To begin to identify target genes of Sox11 involved in Neuro2a survival and 
differentiation, tailored filter gene arrays containing cDNAs linked to apoptosis and survival 
were used. RNA samples from cultures treated with RA alone were compared to RNA isolated 
from cultures treated with both RA and siRNAs against Sox11. Comparison of probe binding 
intensities showed that expression of several genes changed in response to Sox11 knockdown. 
RT-PCR validation of some candidate Sox11 modulated genes, defined by having at least one 
Sox11 binding site within 2 Kb 5’ of the start codon, showed results consistent with the array 
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analysis.  Genes of interest were TANK, BNIP3, Blk and Bcl10, all of which have the potential 
to influence entry into apoptosis. TANK, which was decreased following Sox11 knockdown, 
may have pro-survival activity and appears to regulate apoptosis through its synergistic 
activation of NFkB with TNF receptor-associated factor 2 (TRAF2). This activation occurs via 
the CD40 and tumor necrosis factor receptor 1 surface membrane receptors (Cheng and 
Baltimore, 1996).  BNIP3, a pro-apoptotic gene regulated through nitric oxide signaling (Yook et 
al., 2004), was increased following Sox11 knockdown. Transfection of BNIP3 into MCF-7 and 
Rat-1 cells induced a rapid onset of apoptosis (Chen et al., 1999) whereas siRNA knockdown of 
BNIP-3 blocked cell death (Manka et al., 2005). TANK and BNIP-3 expression were both 
significantly changed after knockdown of Sox11 in RA-treated Neuro2a cells suggesting that 
Sox11 normally acts to transcriptionally regulate these genes in early phases of RA-induced 
differentiation. Consistent with this possibility is that the 5’ regulatory regions of TANK and 
BNIP3 contain 4 Sox binding domains, compared with only one domain in the Blk and Bcl10 
genes (Fig. 7B). Blk, a pro-apoptotic, mitochondrial membrane associated protein that interacts 
with the anti-apoptotic protein Bcl2 (Hegde et al., 1998), was increased on the gene array but 
further RT-PCR validation showed only a trend toward increased expression. Bcl10 was also 
unchanged on both gene array and RT-PCR analysis.  
The requirement for Sox11 in Neuro2a differentiation and survival following RA 
stimulation parallels findings from other studies of Sox factors in cell lines induced to 
differentiate using RA stimulation. As previously mentioned, Sox6 was important for 
differentiation and neurite outgrowth in the RA-stimulated EC cell line P19 (Hamada-Kanazawa 
et al., 2004). Similarly, human EC cells induced to differentiate with RA showed regulation of 
Sox2 and Sox3 expression (Stevanovic, 2003). How each of the different Sox factors regulates 
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gene expression and entry into differentiation programs following RA-stimulation is yet to be 
defined. These studies do indicate however, that the Sox gene family has key roles in regulating 






4.0  DEVELOPMENTALLY REGULATED TRANSCRIPTION FACTOR SRY-BOX 
CONTAINING GENE 11 (SOX11) IS NECESSARY FOR SURVIVAL AND AXON 
OUTGROWTH OF PRIMARY DORSAL ROOT GANGLION NEURONS 
4.1 INTRODUCTION 
SRY-box containing gene 11 (Sox11) is known to be associated with neuronal maturation 
(Hargrave et al., 1997) and prevention of cell death during differentiation (Jankowski et al., 
2006).  Sox11 is upregulated during the stage of development that is associated with initial 
neurotrophin responsiveness and axon outgrowth of primary sensory neurons (Hargrave et al., 
1997; Mirnics and Koerber, 1995; Oppenheim, 1991; Uwanogho, 1995) suggesting that it may 
play a role in how neurotrophins regulate sensory neuron survival and branching in the target of 
innervation.  The upregulation of Sox11 occurs prior to the stage of rapid cell death in the dorsal 
root ganglion (Figueiredo et al. 2001; Pinon et al., 1996) and inhibition of Sox11 during 
differentiation of Neuro2A cells induces apoptosis (Jankowski et al. 2006).  Sox11 was thus 
hypothesized to play a dual role during neuronal maturation; one which promotes differentiation 
and one which prevents programmed cell death during differentiation.  
 
 Several genes have been implicated in the injury response in adult mice after nerve 
damage.  For example, activated transcription factor 3 (ATF3) is not normally present in adult 
DRG neurons; however, after nerve axotomy, ATF3 is upregulated and readily detectable in the 
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injured neurons (Lindwall et al., 2004; Tsujino et al., 2000) and after dissociation and culturing 
the cells (Seijfers et al., 2006).  Changes in ATF3 expression were hypothesized to play a role in 
axon regeneration.  After injury, not only do neurons need to induce axon regeneration 
machinery, but they must also prevent the induction of apoptotic pathways that may accompany 
cellular stress (Perrelet et al., 2002; Kutulska et al., 2005).  Axotomy does not typically induce 
the expression of pro- or anti-apoptotic genes (Burnand et al. 2004), but survival of DRG 
neurons from injury has been linked to the activation of the NFkB pathway (Ferryhough et al., 
2005) and JNK signaling (Keramaris et al. 2005).  Sox11 appears to regulate multiple genes 
associated with apoptosis (Jankowski and Albers, 2006) and has also been linked to nerve injury 
(Jankowski et al. 2004; 2005).  In this portion of study, we examine the role of Sox11 in axon 
growth and neuron survival in adult DRG. 
 
 Using primary DRG neurons as an in vitro model of axotomy (Jankowski et al., 2005; 
Seijfers et al., 2006), we found that Sox11 is significantly upregulated, similar to its upregulation 
following axotomy of the sciatic nerve (Jankowski et al., 2004; Chapter 1 and 5).  Previous 
studies have show that this in vitro system displays similar transcriptional and growth features as 
axotomy (Seijfers et al., 2006; Smith and Skene, 1997).  Over time in culture, sensory neurons 
extend axons and develop intricate neuronal networks.  Penetratin-1 conjugated siRNAs 
(Davidson et al., 2001) directed against Sox11 blocked this outgrowth and caused some the DRG 
neurons to undergo apoptosis as evidenced by immunoreactivity to activated caspase3.  The 
knockdown of Sox11 expression using siRNA transfection of primary DRG neurons also 
induced an increase in genes known to be associated with apoptosis as well as a decrease in 
genes known to regulate neurite growth and nerve regeneration. 
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4.2 MATERIALS AND METHODS 
Primary neuron culture: Male C57/Bl6 mice approximately 2-3 months of age were anesthetized 
with 2.5% avertin and intracardially perfused with 35mL of Hank’s balanced salt solution 
(HBSS; Gibco).  DRGs were dissected away and placed into ice cold HBSS.  DRGs were then 
incubated in 3mL of filter sterilized HBSS containing 1mg l-cysteine, 60U papain (Worthington) 
and 3µL of NaHCO3 at 37oC for 10 minutes.  Solution was removed and 3mL of filter sterilized 
HBSS containing 12mg collagenase II (Worthington) was added to the DRGs and incubated for 
an additional 10 minutes at 37oC.  Collagenase solution was removed and DRGs were washed in 
1-2 mL of F12 complete growth media (F12 containing 10% fetal bovine serum (FBS) and 1% 
penicillin/streptomycin; Gibco).  Media was removed and replaced with 1mL F12 complete 
media containing 50ng/mL of nerve growth factor (NGF; Harlan).  DRGs were triturated 10-20 
times with fire polished glass Pasteur pipettes.  Cells were plated into six wells of a 12-well 
culture dish or onto sterile glass coverslips in a 2-well chamber slide coated with 1mg/mL poly-
d-lysine/ 20mg/mL laminin in HBSS (Sigma).  Cells were allowed to incubate for one to two 
hours at 37oC/ 5%CO2.  Cells were then flooded with 1mL of F12 complete growth media 
containing NGF (50ng/mL) and incubated at 37oC/ 5% CO2 for the appropriate times.   
 
Penetratin-1/ siRNA linkage:  The use of Penetratin-1 linked siRNAs was used to enhance the 
transfection efficiency of adult primary neurons in vitro since adult neurons are not readily 
transfected and many transfection reagents can induce cell death (Davidson et al., 2001).  Non-
targeting and Sox11 targeting siRNAs were obtained from Dharmacon (Minnesota) containing a 
5’ thiol modification on the sense strands.  The non-targeting siRNA duplex also was 
synthesized with a 5’ CY3 molecule conjugated to the antisense strand.  Activated Penetratin-1 
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(Q-Biogene) was reconstituted in sterile water and siRNAs were reconstituted in 1X siRNA 
buffer (Dharmacon).  Equimolar concentrations of activated penetratin-1 were added to each of 
the reconstituted siRNAs and incubated at 65oC for fifteen minutes followed by incubation at 
37oC for one hour.   Stocks were brought up to 400nM NaCl to enhance solubility of penetratin 
linked siRNAs (Pen-siRNAs) and kept at -80oC until used. 
 
Penetratin-siRNA transfection of primary DRG neurons:  Pen-siRNAs were heated to 65oC for 
15 minutes prior to DRG neuron transfections.  When DRG neurons were flooded with F12 
complete media containing NGF (see above), 500µL was removed and either penetratin-1 linked 
control (non-targeting; PenCON) and/ or penetratin-1 linked Sox11 (targeting; PenSox) siRNAs 
were added to the media that was removed.  Pen-siRNAs were mixed by gentle pipetting and 
added back to the cultures dropwise as a 2X solution for a final concentration of 80nM siRNAs 
per well.  Cells were then allowed to re-incubate at 37oC/ 5% CO2 for the appropriate times. 
 
RNA Isolations: RNA isolation was performed using Qiagen RNeasy mini kit for animal cells or 
animal tissues.  Briefly, for primary DRG neuron RNA isolation, media was completely removed 
from culture wells and cells were washed with 0.1M PBS.  400-500µL of buffer RLT containing 
10µL/1mL of β-mercaptoethanol (β-ME) was added directly to the culture dish to lyse the cells. 
Cells were homogenized with the pipette tip and homogenate was added to an RNase-free tube.  
One volume of 70% ethanol in RNase-free water was added to the samples, mixed by pipetting 
and added to an RNeasy-Spin column.  Samples were centrifuged at 10,500 rpm for 15 seconds 
then underwent several other centrifugations using buffers RW1 or RPE (Qiagen).  RNA was 
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eluted from the column in 30-35 µL of RNase-free water.  RNA concentrations were determined 
by obtaining A260 readings on a GeneQuant spectrometer. 
 
RT-PCR/ Realtime PCR: Purified RNA was treated with DNase I (Invitrogen) for 15 minutes at 
room temperature and 1 µg of DNased RNA reverse transcribed in the following manner: 1 µL 
of random primers were annealed to the DNased RNA by incubating at 68oC for 10 minutes 
followed by cooling on ice for 5 minutes. A mixture of 5X First Strand Synthesis buffer, 0.1M 
dithiothreitol, 25mM dNTPs, RNase inhibitor and sterile water was then added to make a 20 µl 
total volume.  Samples were mixed, incubated at 37oC for 2 min, 1 µL of Superscript II Reverse 
Transcriptase (Invitrogen) was added to each sample and they were incubated at 42oC for 50 
min.  Samples were then incubated at 70oC for 15 min, cooled on ice for 5 min. and then stored 
at -80oC until used in PCR reactions. 200 ng of DNA was used in 32P-dCTP spiked PCR 
reactions and products run on an 8% polyacrylamide gel at 400V, blotted onto Whatman 3MM 
paper, dried and exposed to a phosphorimager screen read using a BioRad phosphoimager.  For 
realtime PCR, 20ng samples of cDNA were added to a SYBR Green MasterMix (Applied 
Biosystems) and run in triplicate on an Applied Biosystems Imager. Values were normalized to 
GAPDH or neuronal specific enolase (NSE).  Changes in expression are reported as a ∆∆Ct 
value that is calculated by subtracting the gene expression by the GAPDH/ NSE control for each 
sample and compared among samples.  Fold change is described as 2∆∆Ct (Applied Biosystems). 
 
Immunocytochemistry: For cultured neurons, media was removed from cells at the designated 
times and rinsed in phosphate buffered saline (PBS).  Cells were then fixed in 4% 
paraformaldehyde for 5 min and were then rinsed again in PBS.  Cells were then blocked in 
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0.25% triton X-100 with 5% normal goat serum in PBS or 0.25% triton X-100 in PBS for 30 
min.  Incubation in rabbit cleaved caspase3 (casp3*; 1:100; Cell Signaling Technologies), goat 
Sox11 (1:8000; Aves Labs), mouse N52 (1:500; Sigma) or goat PGP 9.5 (1:500, Ultraclone) 
overnight at room was followed by washing in PBS and a 2h secondary antibody labeling (CY3 
conjugated donkey anti rabbit; CY2-conjugated goat anti rabbit, goat anti mouse or donkey anti 
goat; FITC-conjugated donkey anti rabbit antibody; biotinylated donkey anti-goat (1:500 in 
PBS).  Cells processed for immunofluorescence were rinsed in PBS, sections were mounted onto 
superfrost slides (VWR) and coverslipped in glycerol.  For certain conditions, cells were 
incubated in 4,6-diamino-2-phenyl-indole, dihydrochloride (DAPI; 1:300 in PBS) for five 
minutes and rinsed again in PBS before being coverslipped.  Images were taken on a Leica 
fluorescence microscope or an Olympus BH-2 microscope equipped with differential 
interference contrast (DIC) optics.  Cells incubated in biotinylated secondary antibodies were 
rinsed in PBS and incubated in avidin biotin perixidase complex (ABC; 1:500 in PBS) for one 
hour.  Cells were then rinsed again in PBS and underwent reaction in 3,3-diaminobenzidine in 
sterile water with H2O2 (0.03%) as a cofactor for an empirically determined mount of time.  Cells 
were then rinsed in PBS, PB and sterile water.  Cells were then dehydrated in an ethanol series 
and xylenes before being coverslipped in DPX (Fluka Biochemicals) with photoetched gridded 
coverslips (EMS).   Images of cells were taken on a Leica DMRX microscope. 
 
In vitro quantification of cell death and axon outgrowth: Cells grown on chamber slides were 
processed for either activated caspase3 or protein gene product (PGP) 9.5 immunocytochemical 
labeling as described above.  10-30 total PGP 9.5 stained cells per condition within gridlines of 2 
randomly selected squares on opposite ends of the grid each 600 µm2 using a photoetched 
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gridded coverslip (Electron Microscopy Sciences) at 20x magnification (n=3 per condition; 387 
total cells) were quantified for neurite outgrowth using NIH Image software.  Neurite outgrowth 
was quantified by measuring the total length of all primary neurites and obtaining an average 
length and average maximum length per neuron and counting the number of branch points per 
neurite.  Branching index was then calculated as the number of branch points divided by the 
number of primary neurites on each neuron.  Cells immunolabeled for casp3* were reported as a 
percentage of total cells within 4 randomly selected fields at 20x magnification (n=3 per 
condition; 2178 total cells) on the fluorescence microscope; a field approximately equilvalent to 


















4.3.1 Sox11 is expressed in primary DRG neurons undergoing neurite outgrowth.   
Analysis of primary DRG neurons grown in vitro shows that Sox11 is upregulated over 
time as neurons extend neurites (Fig 10).  mRNA levels of Sox11 are increased slightly (41%) at 
3h and gradually increases 233% by four days in vitro relative to the mRNA level detected 
immediately after dissociation and plating (0h).  The increase in Sox11 mRNA coincides with 
the rate at which primary neurites and higher order branches are formed on DRG neurons (Fig. 
11).  Neurite growth is readily detected in primary DRG neurons within 24h and length and 
branching continues to increase the longer neurons are allowed to grow in vitro (Fig. 11; Table 
3).  Because cultured DRG neurons can regenerate axons, and they upregulate Sox11 while 
doing so, we used DRG cultures as an axotomy model and analyzed the functional consequences 
of siRNA mediated knockdown of Sox11 on survival and neurite growth.  Since adult primary 
DRG neurons are difficult to transfect, we used siRNAs directed against Sox11 that were 
conjugated to the lipophillic peptide Penetratin-1.  Penetratin-mediated delivery of siRNAs 
greatly enhances transfection efficiency of primary DRG neurons from 1% to 90% in vitro (Fig. 














Fig. 10: Percent change in expression of Sox11 mRNA in primary DRG neurons in vitro 
transfected with control (PenCON) or Sox11 (PenSOX) siRNAs.  In PenCON transfected 
cultures, Sox11 mRNA gradually increases over time (blue line).  In PenSOX transfected DRG 
cultures however, Sox11 mRNA is inhibited for at least 24h and does not return to normal levels 





Fig. 11: Light micrographs of primary DRG neurons at 1, 4 and 7 DIV immunoreactive for 
neurofilament. Panel A shows neurons cultured for 24 hours.  Neurite branching is typically in 
all directions from the cell body.  Panel B shows neurons cultured for 4 days.  Neurites are 
beginning to be grouped together (facing arrows) and punctuate labeling suggests synaptic 
incidence (yellow arrow).  Panel C shows primary neurons grown in culture for seven days.  














Fig. 12:  Light micrographs of primary DRG neurons transfected with siRNAs that are linked to 
a CY3 tag that were unconjugated (A) or conjugated to Penetratin-1 (B).  Transfection of adult 
primary DRG neurons with siRNAs not conjugated to penetratin-1 results in low transfection 
efficiency (A), whereas conjugation to penetratin-1 greatly increases the transfection efficiency 
(B). Panels C and D show labeling of cultures with the nuclear stain DAPI.
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            Transfection of primary DRG neurons with penetratin linked siRNAs directed against 
Sox11 (Pen-SOX siRNAs) caused a transient but significant knockdown of Sox11 mRNA.  
Knockdown of Sox11 mRNA lasted at least 24h and returned to control levels (PenCON 
siRNAs) by four days (Fig. 10).  Immunocytochemical localization of Sox11 shows that 
PenCON transfected DRG neurons had heavy nuclear and low to moderate cytoplasmic staining 
for Sox11 protein (not shown) whereas PenSOX transfected DRG neurons showed minimal 
cytoplasmic staining for Sox11 protein and no nuclear staining (Fig. 13).  Initial knockdown in 
Sox11 protein could be detected as early as 3hr in a small percentage of cells (not shown).  The 
largest knockdown in protein expression was detected at 24h (Fig. 13).  After four to seven days 
in vitro (DIV), Sox11 staining returned to normal levels (not shown).  To confirm that these 
findings were specific to neurons and not contaminating glial cells, primary DRG cultures were 
colabeled with antibodies to Sox11 and NeuN (a neuronal marker) and DAPI, a nuclear dye that 
stains all nuclei.  This analysis showed that only NeuN positive neurons were positive for Sox11 
(Fig. 14).  Non neuronal cells which were NeuN negative and DAPI positive did not label with 
anti-Sox11 (Fig. 14).  Given the specificity of the Sox11 siRNAs (see above), the effects of 
knocking down Sox11 in DRG cultures is highly likely to be specific to neurons. 
 
4.3.2 The increased expression of Sox11 is essential for neurite outgrowth.  
            Since neurite outgrowth correlated to the increase in Sox11 expression in primary DRG 
neurons, we analyzed the functional consequences of Sox11 knockdown on outgrowth by 
measuring neurite length and branching in PenSOX transfected DRG neurons.  At 24h, PenSOX 









Fig. 13: Light micrographs of primary DRG neurons transfected with both penetratin-1 
conjugated, CY3-tagged control siRNAs and Sox11 siRNAs (Pen-siSOX).  24h after 
transfection, cultures were immunolabeled for Sox11.  In transfected cells (Panel A arrows; red), 
no Sox11 immunolabeling is present (Panel B arrows).  Only non-transfected cells show labeling 








Fig. 14: Light micrographs of primary DRG cultures immunolabeled for Sox11 and NeuN and 
stained for DAPI.  Sox11 positive cells (Panel A; arrow) were found to be neuronal (Panel B; 
arrow) and not non-neuronal (Panel C; arrowheads). 
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had a significant decrease in branching compared to PenCON transfected cells (Table 3).   
 
After four DIV, PenSOX transfected cells did exhibit a significant decrease in neurite 
length compared to control transfected neurons at 4d and a continued deficit in branching (Fig. 
15; Table 3).  To determine if all or some of the primary neurites were affected by Sox11 
knockdown, we analyzed maximum neurite length in PenSOX transfected DRG neurons.  The 
average length of the longest primary neurite was not significantly different between PenCON 
and PenSOX treated DRG neurons at 24h but in PenSOX treated cultures it was statistically 
decreased by 4d (Fig. 15; Table 3).   
 
 To determine if particular populations of neurons were differentiatlly affected by Sox11 
knockdown, we analyzed neurite growth in different cell sizes.  Average and maximum neurite 
length was not affected in any population of sensory neurons after Sox11 knockdown at 24h 
(Fig. 16a and e); however, there was a statistically significant reduction in branching index in the 
smallest and largest diameter cells (Fig. 16c).  Medium diameter cells were less affected by 
Sox11 inhibition at 24h.  After four days in vitro, the smallest and largest cells still retained a 
significant reduction in average and maximum neurite length; however, some neurons of 
medium diameter exhibited neurite growth deficits in the absence of Sox11 (Fig. 16b and f).  
Surprisingly, after four DIV, nearly all neuron size classes in PenSOX treated cultures had 















Fig. 15: Light micrographs of primary DRG neurons transfected with control (Pen-siCON) 
and/or Sox11 targeting (Pen-siSOX) siRNAs immunoreactive for neurofilament 200 (N52).  At 
four days, Pen-siCON transfected neurons display longer neurites and enhanced branching 
(panels A and C) while Pen-siSOX transfected neurons do not show enhanced neurite 
lengthening or branching (panels B and D).  In fact, many primary neurites are visibly shorter in 





Fig 16: Cell size histogram of neurite outgrowth in primary DRG neurons transfected with 
control (PenCON) or Sox11 targeting (PenSOX) siRNAs.  There were no detectable differences 
in PenSOX treated cells compared to PenCON at 24h for average length or maximum length; 
however, a few groups of cells had a significant reduction in branching.  At 4d however, several 
groups of cells had problems with neurite lengths (average and maxium) while almost all groups 
displayed deficits in branching indices. * p value < 0.05, relative to controls.
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4.3.3 Primary DRG neurons deprived of Sox11 undergo apoptotic cell death.   
Our data thus far suggested that Sox11 is important for neurite growth and nerve 
regeneration.  However, it was also noticed that the morphology of some of the PenSOX 
transfected cells appeared apoptotic as evidenced by shrunken cell membranes and disrupted 
nuclei (not shown).  We therefore quantified the percentage of PenSOX treated DRG cells that 
expressed activated caspase 3 (casp3*), a marker of apoptosis.  Transfection of DRG cultures 
with PenCON siRNAs caused 11% (59/535 cells) of neurons to express casp3* 
immunoreactivity at 24h.  In contrast, DRG cultures trasnfected with PenSOX siRNAs showed 
20% (127/633 cells) of the cells were immunopositive for casp3*.    At fourDIV, the number of 
PenCON treated cells decreased to 10% (51/507 cells) but the percentage of PenSOX transfected 
DRG cells immunoreactive for casp3* remained at 20% (101/503 cells; Fig. 17; Table 3).  
Because Sox11 is found to be exclusively localized to neurons (Fig. 14), inhibition of Sox11 
with siRNAs in DRG cultures should only directly affect apoptosis in these cells.  Although we 
cannot rule out an indirect affect of Sox11 inhibition in neurons on glial cell apoptosis in these 
experiments, closer examination of cultures immunostained for casp3*, NeuN and DAPI showed 
that activated caspase3 immunoreactive cells in primary DRG cultures were indeed neuronal 
(Fig. 18).  Therefore, we are confident that the quantification of casp3* positive cells in primary 














Fig. 17: Immunocytochemical localization of activated caspase3 (casp3*) in primary DRG cells 
transfected with either control (Pen-siCON) and/or Sox11 targeting (Pen-siSOX) siRNAs and 
stained for DAPI.  At four days in vitro, Pen-siCON transfected cells show minimal 
immunoreactivity for casp3* (panel A) whereas Pen-siSOX transfected cultures show enhanced 
casp3* immunolabeling (panel C).  DAPI staining was performed to show presence of all cells in 






Fig. 18: Light micrographs of primary DRG neurons transfected with Sox11 targeting (PenSOX) 
siRNAs immunolabeled for activated caspase 3 (casp3*), neuronal specific nuclear protein 
(NeuN) and nuclear stain, DAPI at 24h in vitro.  Immunolabeling of PenSOX transfected DRG 




4.3.4 Knockdown of Sox11 alters the expression of genes associated with neurite 
outgrowth and apoptosis.  
Because knockdown of Sox11 in primary DRG neurons in vitro causes deficits in neurite 
growth as well as induction of apoptosis in some cells, we sought to determine the mechanism by 
which Sox11 might be mediating these changes.  To determine if known outgrowth associated 
genes were differentially regulated by Sox11 knockdown, we analyzed the expression of brain 
derived neurotrophic factor (BDNF), small proline rich protein 1a (Sprr1a), profilin, actin related 
protein 2/3 complex subunits 3 and 4 (Arpc3 and 4), and activated transcription factor 3 (ATF3) 
in DRG neurons transfected with PenSOX siRNAs over time.    Each of these genes has multiple 
Sox11 binding sites in the upstream promoter region.  BDNF (2 binding sites with in 0.5kb), 
Arpc4 (4 sites within 2kb) and profilin (2 sites within 2kb) were not significantly altered by 
Sox11 knockdown at any timepoint analyzed (not shown).  However, Sprr1a (3 sites within 2kb) 
was increased, and Arpc3 (3 sites within 2kb) and ATF3 (2 sites within 2kb) were decreased by 
Sox11 inhibition at 3h and 24h and returned to control levels by 4d (Table 4).   
 
We then used tailored realtime PCR profiler gene arrays to simultaneously analyze the 
expression of 88 genes involved in the process of apoptosis in DRG neurons treated with 
PenSOX siRNAs at 24h We chose to analyze expression at the 24h timepoint since the induction 
of caps3* immunoreactivity first appeared at this time and lasted for several days thereafter.  
Twenty-seven apoptosis associated genes were significantly changed as a result of sox11 
knockdown.  Of these, 5 contained Sox11 binding sites in their upstream promoter regions 
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suggesting that Sox11 may directly regulate their expression and were therefore analyzed using 
RT-PCR (Table 4).  Traf member and activator of NfkB, or TANK (5 sites within 2kb) was 
initially decreased by lack of Sox11 but surpassed control levels by four days in vitro.  Traf1 (3 
sites within 2kb) showed a trend toward increased expression as a result of Sox11 inhibition at 
all time points tested but was not statistically significant.  BH3-interacting domain death agonist, 
or Bid (5 sites within 3kb) was decreased in PenSOX treated cultures at 3hr, but was increased at 
24h and 4d although also only showed a trend toward statistical  significance (Table 4).   
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The data described herein show that the developmentally regulated Sox11 transcription 
factor has an important role in survival and neurite growth in primary DRG neurons.  Our 
previous study showed that Sox11 was necessary for Neuro2A survival and differentiation in 
response to retinoic acid application (Jankowski et al. 2006).  A similar mechanism may function 
in cultured adult primary DRG neurons with reduced levels of Sox11.  Inhibition of Sox11 in 
primary DRG neurons induces some cells to undergo apoptosis and express activated capsase3 
immunoreactivity.  These neurons also displayed abnormalities in neurite growth and branching 
suggesting a role for Sox11 in peripheral nerve regeneration.   
 
4.4.1    Sox11 is Involved in Neuronal Survival and Differentiation.   
In this study we have shown that Sox11 is an important regulator of neurite growth and 
branching in primary DRG neurons and neurons with reduced levels of Sox11 are more 
susceptible to apoptosis.  Primary DRG neurons grown in vitro enhance their levels of Sox11 
mRNA in relation to the extent of neurite growth and branching.   Using Penetratin-1 linked 
siRNAs directed against Sox11, we have shown that primary DRG neurons are readily 
transfected with high efficiency and display a transient but effective knockdown of Sox11 
mRNA and protein.  A near complete knockdown of Sox11 in primary DRG neurons does not 
occur until 24hrs which may explain the lack of a significant deficit in neurite extension at the  
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24h timepoint.  However, at 4 DIV, neurite growth is clearly inhibited in cells transfected with 
PenSOX siRNAs relative to PenCON transfected neurons.  Control DRG neurons continually 
grow longer neurites in vitro whereas PenSOX transfected cells halt their neurite extension 
suggesting that Sox11 is necessary for continued neurite elongation and outgrowth.  In contrast 
to neurite length analysis, branching indices indicate that higher order branching of primary 
neurites is affected immediately upon inhibition of Sox11.  The BI is decreased in PenSOX 
transfected neurons with in 24h of transfection compared to PenCON transfected neurons.  BI is 
also halted for several days, similar to what is shown with average neurite length.  These features 
of neurite growth appear to affect all primary neurites extending from the somas since maximum 
neurite length is affected to the same degree by PenSOX siRNA transfection as average neurite 
length.   
 
This study also showed that 20% of DRG neurons undergo apoptosis as a result of Sox11 
inhibition similar to previous studies (Jankowski et al. 2005; 2006).  It is unclear if the 
population of cells that display outgrowth deficits are the same as those that are casp3* 
immunopositive.  Analysis of cells that were processed for neurite outgrowth measurements 
suggests that more cells display neurite extention and branching deficits than those that are 
casp3* positive (not shown).  This would suggest that neurite growth is affected in all cells by 
Sox11 inhibition whereas only a small population of those cells will undergo programmed cell 
death.  It is not clear if the degree of Sox11 inhibition or some other factor contributes to cell 
death in neurons that lack sufficient levels of Sox11.  To address this, future experiments can 
determine if the degree of Sox11 inhibition in individual cells correlates with expression of 
apoptotic markers.   
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4.4.2 Sox11 Regulates the Expression of Genes Associated with Neurite Outgrowth and 
Apoptosis.   
Microarray analysis of cultures treated with Sox11 siRNA showed that knockdown of 
Sox11 in DRG neurons modulated expression of genes involved in neurite extension and 
programmed cell death.  Genes that appeared to be modulated on arrays were selected for further 
RT-PCR validation based on whether their proximal regions (2-3Kbp of the transcriptional start 
site) contained Sox consensus binding domains.  The presence of Sox binding sites greatly 
enhances the probability that these genes are activated/ repressed by Sox11.   
 
Sprr1a is upregulated in the brain after trauma (Marklund et al., 2005) and is known to 
promote neurite outgrowth of primary DRG neurons and enhance peripheral nerve regeneration 
(Bonilla et al., 2002).  Like many genes in Sox11 siRNA treated DRG cultures, the change in 
Sprr1a expression was dynamic, with no change early on, upregulation after 24h and return to 
control levels by four DIV.  Sprr1a has 3 Sox consensus sites in its proximal promoter allowing 
for the possibility that Sox11 contributes to its transcriptional regulation.  Little is known about 
Arpc3 and its role in neurite growth.  It is known that Arpc3 is present at the site of active actin 
filament assembly (Welch et al., 1997) and necessary for actin filament branching (Volkmann et 
al., 2001).  Sox11 significantly regulates the expression of Arpc3 in primary DRG neurons 
suggesting it may have a role in neurite growth.  The transcription factor ATF3 is known to be 
associated with neurite sprouting (Pearson et al., 2003) and is induced in cells upon injury 
(Campbell et al., 2003; Isacsson et al., 2005; Lindwall et al., 2003; Tsujino et al., 2000).  ATF3 
 78 
mRNA was highly regulated by the level of Sox11 in primary DRG neurons.  ATF3 has two Sox 
binding sites in its proximal promoter and could therefore be modulated by Sox11 expression. 
Although ATF3 has Sox binding sites, no ATF3 binding sites are present in the proximal 
promoter of Sox11 suggesting ATF3 does not regulate Sox11. 
 
Sox11 knockdown also alters expression of genes associated with survival and apoptosis.   
Traf1 is a mediator of cell death that interacts with tumor necrosis factor receptors (Lee and Lee, 
2002) and regulates of c-Jun N-terminal kinase (JNK) and members of the NfkB signaling 
pathway (Cha et al., 2003).  Traf1 has 3 Sox binding sites and Sox11 knockdown enhances Traf1 
expression at all time points tested.  Thus, Sox11 may have direct control over the transcription 
of this mediator of apoptosis.  TANK was reduced following siRNA inhibition of Sox11 
(Jankowski et al., 2006), and appears to be a pro-survival gene that interacts with NfkB signaling 
pathways (Cheng and Baltimore, 2003).  TANK has five Sox binding sites within 2 kb of the 
transcriptional start site and is another candidate for direct regulation by Sox11.  Although these 
data suggest that Sox11 can regulate the expression of genes associated with neurite growth and 
apoptosis, reporter assays and chromatin binding studies to show direct interaction at the 
consensus sequence will be necessary to confirm these interactions. 
 
4.4.3  Conclusions.   
 
The results from these studies parallel previous findings using the neuroblastoma cell line 
Neuro2A and indicate that Sox11 regulates transcription of genes involved in control of 
apoptosis and neurite growth in adult sensory neurons in vitro.  Knockdown of Sox11 in DRG 
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neurons by transfection of Penetratin-linked siRNAs induced a two-fold increase in the number 
of apoptotic cells and an arrest in neurite growth that lasted for several days.  Potential 
downstream targets of Sox11 action in relation to apoptosis include the TANK and Traf1 genes, 
both of which are linked to cell survival.  Sox11 also appears to play a role in axon growth, 
possibly through its regulation of pro-neurite growth genes like ATF3, Sprr1a and Arpc3.  Given 
these outcomes, we continued our studies to determine if Sox11 has a role in adult injury 







5.0  SOX11 IS REQUIRED FOR EXPRESION OF ATF3 AND NERVE 
REGENERATION IN VIVO. 
5.1 INTRODUCTION 
 In adult mammals, mechanisms of repair and survival that are stimulated following nerve 
injury in DRG neurons may in some ways reactivate those stimulated during embryonic 
development (Bahr, 2000; Silver, 1994).  Several genes have been implicated in the injury 
response in adult mice after nerve damage.  Activating transcription factor 3 (ATF3) in particular 
is not normally present in adult DRG neurons; however, after nerve axotomy, this transcription 
factor is upregulated and readily detectable in the injured neurons (Tsujino et al., 2000).  ATF3 
has not been specifically linked to development of sensory neurons, but it has been linked to pro-
apoptotic and survival functions depending on the tissue type (Fan et al., 2002; Hai and Hartman, 
2001; Hartman et al., 2004).  In the nervous system, it appears to be associated with survival and/ 
or neurite outgrowth (Lindwall and Kanje, 2005; Seijfers et al., 2006).  Many developmentally 
regulated genes have also been shown to play a role in adult mice after peripheral nerve injuries, 
e.g., c-jun (Lindwall et al., 2004; Pearson et al., 2003) and extracellular signal related protein 
kinase (ERK; Chierzi et al. 2005; Doya et al., 2005; Obata et al. 2004).  Although each of these 
genes plays an essential role in the injury response, it is unclear whether these genes are 
necessary for nerve regeneration in vivo.    
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The mechanisms of regenerating peripheral and central axons are different in many 
aspects.  Differences mainly lie in the presence of inhibitory enzymes in the CNS that are either 
not present or inhibited in the periphery (Kury et al., 2001; Qiu et al., 2001) and a lack of 
transcriptional mechanisms that are normally induced in the PNS that are not induced in the CNS 
(Kenny and Koscis, 1997).  Once these mechanisms are initiated, several events occur to 
regenerate peripheral axons.  After injury to a nerve, a period of “dying back” from the site of 
injury and initiation of Wallerian Degeneration occurs during the first several days (Baba et al., 
1982; Mi et al., 2005; Sebille, 1982; Thomas, 1982).  Wallerian Degeneration (WD) is a 
response that occurs upon injury to peripheral nerves that serves to degenerate the injured axons 
and clear a path for the axons to regenerate.  Studies have shown that WD involves many 
processes including macrophage infiltration, glial cell proliferation, and ubiquitination followed 
by transcription of pro-regeneration genes.   
 
For DRG neurons to undergo successful regeneration, they must induce anti-apoptotic 
mechanisms to avoid neuron death following injury.  Several pro- and anti-apoptotic genes are 
differentially regulated in the DRGs after axotomy (Costigan et al., 2002) and many are not 
changed (Burnand et al., 2004).  The transcription factor Sox11 has been shown to regulate anti-
apoptotic mechanisms in primary DRG cultures and neurite growth (Jankowski et al., 2006).  
The dual function of this developmentally regulated transcription factor makes it an attractive 
candidate to be a master regulator of the adult injury response.  In the current study, we further 
investigate the role of Sox11 in DRG axon regeneration and neuron survival in adult mice after 
nerve injury.   
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The effects of Sox11 knockdown in vitro prompted us to analyze its effects in vivo 
following saphenous nerve axotomy or crush.  The saphenous nerve injury model was chosen 
due to the simplicity of surgery and the fact that the axonal composition of the saphenous nerve 
is well characterized.  The saphenous nerve extends from lumbar DRGs L2 and L3 in the mouse 
and is a purely cutaneous nerve that is comprised of 80% unmyelinated small and medium 
diameter fibers and 20% myelinated axons (Baron et al. 1988; Stucky et al. 1999).  These axons 
innervate hairy skin from the mouse knee to regions on the foot extending to the toes (Kitao et 
al., 2003; Koltzenberg et al., 2000).  Saphenous nerve crush was found to induce a similar level 
of Sox11 mRNA elevation in the L2/L3 DRGs as previously shown after saphenous or sciatic 
nerve axotomy (Jankowski et al., 2004; 2005).  Because nerve crush is an injury that has a more 
consistent regeneration profile than nerve cut we chose to use this approach. We found that 
Penetratin-1 linked Sox11 siRNAs injected into the saphenous nerve were retrogradely 
transported to the cell bodies and induced a knockdown in Sox11 mRNA expression.  Targeted 
siRNA injection into the saphenous nerve prior to axotomy or nerve crush also induced a 
knockdown in the pro-regeneration gene ATF3 and decreased the extent of regeneration 
compared to control injected and crushed nerves.  These data suggest that Sox11, a 
developmentally regulated transcription factor associated with neuronal maturation and survival, 






5.2 MATERIALS AND METHODS 
 
Sciatic/ Saphenous nerve axotomy/ crush and siRNA injections: Male Swiss Webster mice 
(Hilltop) approximately 4-6 weeks of age were anesthetized by a mixture of ketamine and 
xylazine (90 mg/kg and 10 mg/kg, respectively) for saphenous nerve injury.  A small incision 
was made in the groin area over the saphenous nerve.  The nerve was cleaned of connective 
tissue, transected and wounds closed using 7.0 silk sutures.   Sciatic nerve axotomized mice were 
placed in an enclosed chamber for initial anesthetization by isofluorane and then fitted into a 
facemask to receive isofluorane throughout the procedure.   The animal was closely shaved on 
the left side, the skin wiped with betadine and an incision made at the lumbar level. A mini-
Goldstein retractor (Fine Science Tools, Foster City, CA) was inserted into the incision and 
opened, providing an area in which to work. Once identified, the sciatic nerve was tightly ligated 
with 6.0 silk sutures and transected distal to the suture. The muscles were then sutured and the 
wound was closed with microclips (Roboz, Gaithersburg, MD).    
 
 Nerve crush was performed using number 5 forceps (Fine Science Tools, Forester City, 
CA) held together for approximately 4-5 seconds.  Incisions were closed using 2.0 silk sutures.  
In animals that received siRNA injection, 0.3-0.4µL of 90µM Penetratin-1 linked control 
(PenCON) or Sox11 targeting (Pen-SOX) siRNAs were pressure injected directly into the 
saphenous nerve using a glass microelectrode connected to a pico-spritzer.  All nerve cuts/ 
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crushes were made distal to the injection site approximately 1-2mm without cleaning the 
surrounding area and without damage to any blood vessels.  Animals were allowed to survive for 
2-28 days after nerve injury for immunocytochemical, electron microscopic and/ or PCR 
analysis.   
 
RNA Isolations: All RNA isolations were performed using Qiagen RNeasy mini kit for animal 
tissues.  For fresh DRGs RNA isolation, animals were anesthetized with ketamine/ xylazine and 
intracardially perfused with ice cold 0.9% NaCl.  Ganglia were removed and placed in RNase-
free tubes on dry ice.  Then 500µL of β-ME containing RLT buffer was added to the ganglia and 
homogenized with a polytron generator for 1 minute.  Homogenates were centrifuged at 14,000 
rpm for three (3) minutes and supernatant was transferred to an RNase-free tube.  One volume of 
70% ethanol in RNase-free water was added to the samples, mixed by pipetting and added to an 
RNeasy-Spin column.  Samples were centrifuged at 10,500 rpm for 15 seconds then underwent 
several other 15sec to 2min centrifugations using buffers RW1 or RPE (Qiagen).  RNA was 
eluted from the column in 35 µL of RNase-free water.  RNA concentrations were determined by 
obtaining A260 readings on a GeneQuant spectrometer.  RT reactions and realtime PCR were 
performed as described previously (Chapter Three; Jankowski and Albers, 2006). 
 
Immunocytochemistry:  Animals were anesthetized with a lethal dose of ketamine/ xylazine and 
intracardially perfused with 4% paraformaldehyde.  Ganglia were then postfixed in 4% 
paraformaldehyde for 1 hour and rinsed in PBS.  Ganglia were removed and embedded in 10% 
gelatin in 0.1M PB. Sections were cut at 50µm and collected in 0.1M PBS.  Sections were rinsed 
3x in 0.1M PBS and then blocked in 0.25% triton X-100 with 5% normal goat serum in PBS for 
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30 min.  Incubation in rabbit cleaved caspase3 (casp3*; 1:100; Cell Signaling Technologies), 
goat Sox11 (1:100; Santa Cruz), or rabbit ATF3 (1:500, Santa Cruz) overnight at room was 
followed by washing in PBS and a 2h secondary antibody labeling (CY3 conjugated goat anti 
rabbit; CY2-conjugated goat anti rabbit or anti goat; FITC-conjugated donkey anti rabbit 
antibody; 1:500 in PBS).  Sections were rinsed in PBS, sections were mounted onto superfrost 
slides (VWR) and coverslipped in glycerol.  Images were taken on an Olympus confocal 
fluorescence microscope and complied in Adobe Photoshop. 
 
Electron Microscopy.  Animals for electron miscroscopic analysis were intracardially perfused 
with ice cold saline.  Saphenous nerves were exposed and fixed with 2% gluteraldehyde/ 4% 
paraformaldehyde in the animal for 5 minutes prior to dissection.  Once dissected, the nerves 
were post fixed in 2% gluteraldehyde/ 4% paraformaldehyde for two hours.  Nerves were then 
cut into 1mm blocks, post-fixed in 2% osmium tetroxide in 0.1M PB for one hour and 
dehydrated in an increasing series of ethanols and propylene oxide.  Blocks were then embedded 
in EMBed 812 (Electron Microscopy Sciences).  Ultra-thin sections (80-90nm) were cut with an 
ultramicrotome and collected on formvar/ carbon coated copper slot grids.  Grids were counter 
stained in uranyl acetate and lead citrate and analyzed on a Morgagni electron microscope.  
Images were captured using AMT digital imaging software and digital camera connected to the 
microscope.  Images taken of the entire nerve at 4400x were compiled into montages using 
Adobe Photoshop. 
 
In vivo quantification of axon regeneration:  Digital images obtained from EM processing were 
analyzed offline.  After montage construction, numbers of non-degenerating axons of normal 
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appearance were counted in the sections analyzed at seven and 14 days in control and 
experimental mice and averaged across animals (n=3 per condition).  Axons of comparable 
morphologically to uninjured nerves and those not meeting the criteria for electron-dense 
degeneration according to Peters et al. (1991) and Mugnaini and Friedrich (1981) were used to 
establish the criteria for degenerating axons in the saphenous nerve.  These criteria do not meet 
those established for filamentous, flocculent or watery degeneration (Mugnaini and Friedrich, 
1981).  Briefly, degenerating axons were determined to be electron dense with swollen 
mitochondria (when present) and associated with surrounding glial cells.  Numbers of non-
degenerating axons present at 2mm, 4mm and 6mm distal to the site of the nerve crush at various 
times after injury were recorded and presented as an average difference in the number of 
regenerating fibers between PenCON and PenSOX injected mice.  Data were then segregated 
into myelinated and unmyelinated groups to distinguish differences in regeneration rate between 
fiber types.  Statistical significance between conditions was determined using Student’s t-test 






5.3.1 Sox11 is upregulated in DRGs after saphenous nerve axotomy. 
To confirm that Sox11 is upregulated in DRGs of mice with peripheral nerve injury, 
RNA was isolated from the L2/L3 or L4/L5 DRGs of animals that underwent saphenous or 
sciatic nerve axotomy, respectively at three, four, five, seven, 14 and/ or 28 days post nerve 
transection.  The saphenous nerve was chosen due to the simplicity of the procedure, ease of 
access to the nerve and minimal damage that occurs to surrounding tissues due to the surgery.  
Expression assays on the sciatic nerve were done for comparison.  Sox11 mRNA was found to 
be increased in the L2/L3 DRGs 2.84-fold three days post saphenous nerve axotomy and 
continued to increase to 3.47-fold at day five.  Seven days after saphenous nerve axotomy, Sox11 
mRNA was determined to be 3.11-fold higher in the ipsilateral ganglia than the contralateral 
ganglia and returned to baseline after four weeks (Fig. 19a).  Sox11 mRNA was increased 8.73-
fold four days after sciatic nerve axotomy in the L4/L5 DRGs.  Levels of Sox11 mRNA 
continued to increase to a 13.1-fold increase at seven days and fell to 10.1-fold at 14 days (Fig. 
19.   No change in Sox11 mRNA was detected in the spinal cord at any time point after sciatic 





Fig. 19: Fold Change in Sox11 mRNA in L2/L3 DRGS after axotomy of the saphenous and in 
L4/L5 DRGs after axotomy of the sciatic nerves.  A: Saphenous nerve axotomy induces an 
increase in Sox11 mRNA that is increased 2.84-fold within three days, peaks at day five to 3.47-
fold and remains elevated for at east seven days at 3.1-fold.  After four weeks however, Sox11 
mRNA levels returns to baseline.  B: Axotomy of the sciatic nerve shows a similar pattern of 
Sox11 expression four days after axotomy.  Sox11 levels rise 8.73-fold higher than contralateral 
ganglia at four days.  Sciatic nerve axotomy induces a peak in Sox11 mRNA expression at day 
seven where levels reach a 13.1-fold increase.  After two weeks, Sox11 is still elevated 10.1-fold 




            Immunocytochemical analysis of Sox11 expression shows that Sox11 is readily 
detectable after sciatic nerve injury in the ipsilateral L4 DRG but not the contralateral ganglion 
(Fig. 20).  A low level nuclear and cytoplasmic staining is evident under baseline conditions (Fig 
20), but after injury to the sciatic nerve, Sox11 nuclear and cytoplasmic staining is enhanced 
(Fig. 20).  To verify that axotomy induces injury in the DRGs, we performed 
immunocytochemical labeling for ATF3 after saphenous nerve axotomy in the ipsilateral and 
contralateral L3 DRGs.  Nuclear labeling of ATF3 is easily detected in the injured ganglion three 
days after saphenous nerve axotomy but not in the uninjured ganglion (Fig. 20 and d).   
 
5.3.2 Injection of Penetratin-1 conjugated siRNAs against Sox11 into the saphenous nerve 
knocks down mRNA expression.   
To determine if Sox11 upregulation after axotomy was necessary for peripheral nerve 
regeneration and if the effect of Sox11 inhibition on neurite outgrowth in vitro correlated to a 
deficit in axon re-growth in vivo, our approach was to knock down the expression of Sox11 in 
the sensory neurons that contribute to the saphenous nerve. To accomplish this, penetratin-1 
linked control (PenCON) or Sox11 targeting (PenSOX) siRNAs were injected into the saphenous 
nerve.  siRNAs were taken up into nerve fibers and retrogradely transported back to the cell 
bodies in the L2/L3 DRGs (Fig. 21.  Retrograde transport of siRNAs was determined to take 
approximately two days although no RNA knockdown of Sox11 was detected in PenSOX 
injected mice at this time point relative to PenCON injected animals.  PenSOX siRNA induced 
















Fig. 20:  Light micrographs of L4 DRGs immunoreactive for Sox11 seven days after axotomy of 
the sciatic nerve and of L3 DRGs immunopositive for ATF3 three days after axotomy of the 
saphenous nerve.  Sox11 is readily detected in nuclei of the majority of sensory neurons, 
presumably those that were injured by nerve cut on the ipsilateral side (panel A).  Some low 
level staining is detectable on the contralateral side (panel B).  Axotomy also induces expression 
of ATF3 in the ipsilateral L3 DRGs (panel C) three days after axotomy of the saphenous nerve 





Fig. 21: Light micrographs of saphenous nerve and L3 dorsal root ganglion (DRG) from an 
animal injected two days previously with CY3-tagged, Penetratin-1 linked control (PenCON) 
siRNAs.  A: PenCON siRNAs are taken up by the fibers of the saphenous nerve upon injection 
(arrowhead).  B: siRNAs are also readily detectable in axons of the saphenous nerve 4mm 
proximal to the injection site (arrowhead).  C: Whole mount DRGs display several somas that 
also show that the siRNAs are retrogradely transported by evidence of cytoplasmic CY3 
fluorescence in the DRG after saphenous nerve injection of PenCON siRNAs (arrows).   
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underwent saphenous nerve axotomy after three days (Fig. 22).   
 
Animals that were injected with PenCON siRNAs and axotomized had 4.63-fold higher 
levels of sox11 mRNA in the L2/L3 DRGs whereas PenSOX injected animals had only a 3.74-
fold increase in sox11 mRNA.  The increase in expression was found to be higher in animals that 
were both injected and axotomized versus mice that received nerve cut or injection alone (Figs. 
22 and 23; and data not shown).   PenSOX injected mice displayed a higher (4.33-fold) level of 
Sox11 mRNA expression at five days post axotomy than PenCON injected animals; however, 
both controls and experimental groups returned to a similar level of expression (approx. 3.1-fold) 
by day seven compared to axotomized animals alone (Fig. 23).  
 
5.3.3 Inhibition of sox11 in vivo blocks ATF3 expression and nerve regeneration.   
To determine if injection plus axotomy was causing a larger injury than either injury 
alone, we performed realtime PCR analysis for ATF3 on mice that received saphenous nerve 
axotomy alone and on mice that were injected with siRNAs and underwent axotomy.  Saphenous 
nerve axotomy induced a 22-fold increase in ATF3 mRNA three days after injury (not shown), 
whereas axotomy plus injection of siRNAs into the saphenous nerve induced a 26-fold increase 
in ATF3 (Fig. 24).  Surprisingly, injection of PenSOX siRNAs in animals that also experienced 













Fig. 22: Fold change in Sox11 mRNA two and three days after injection of either control 
(PenCON) or Sox11 targeting (PenSOX) siRNAs directly into the saphenous nerve.  No 
detectable knockdown in expression is detected between PenCON (blue line) and PenSOX (red 
line) treated mice two days after injection.  After three days however, PenSOX injected mice 
show a reduction in Sox11 expression relative to PenCON injected mice.  *p value < 0.05, 














Fig. 23: Fold Change in Sox11 mRNA in L2/L3 DRGs from mice injected with non-targeting 
control (PenCON) or Sox11 targeting (PenSOX) siRNAs with or without axotomy of the 
saphenous nerve.  Injection of PenCON (light blue line) and PenSOX (red line) siRNAs plus 
axotomy of the saphenous nerve both cause a larger increase in Sox11 expression compared to 
axotomy alone (dark blue line) at three days (4.63-fold vs. 3.7-fold vs 2.84-fold increase 
respectively).  However, PenSOX injection plus axotomy induces a reduction in Sox11 
expression relative to PenCON injection plus axotomy.   Five days after axotomy and injection, 
PenSOX treated mice show higher levels of Sox11 mRNA (4.33-fold) than both PenCON treated 
mice (3.95-fold) and mice that received an axotomy of the saphenous nerve alone (3.47-fold).   
After seven days, all three conditions show similar expression for Sox11 (PenCON: 3.1-fold 













Fig. 24: Fold Change in ATF3 and Sox11 mRNA three days post saphenous nerve axotomy and 
injection of control (PenCON) or Sox11 targeting (PenSOX) siRNAs.   PenCON injection plus 
axotomy induces a 26.2-fold increase in ATF3 and a 4.63-fold increase in Sox11.  Surprisingly, 
PenSOX injection plus axotomy not only reduced the increase in Sox11 mRNA to a 3.7-fold, but 
it also only permitted a 19-fold increase in ATF3 expression.
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            Based on our previous data that showed that Sox11 is necessary for neurite outgrowth in 
vitro, and that inhibition of Sox11 could alter the levels of ATF3 induced by axotomy, we 
measured how PenSOX siRNA injection altered the rate of regenerating saphenous nerves.  The 
saphenous nerve typically takes 2-4 weeks to functionally regenerate from a nerve transection or 
nerve crush (McIlwrath et al., 2005).  We therefore determined the numbers of axons that 
regenerated after saphenous nerve crush in PenCON and PenSOX injected animals at three, 
seven and 14 days after nerve crush at the electron microscopic (EM) level.  EM is necessary for 
this type of analysis since small diameter fibers cannot be seen at the light microscopic level.  
We first verified that siRNA injection and nerve crush induced similar changes in Sox11 and 
ATF3 as injection of siRNAs and axotomy.  Injection of PenSOX siRNAs inhibited the increase 
in Sox11 and ATF3 induced by injection of PenCON siRNAs in animals that experienced nerve 
crush at three days and seven days.  Both Sox11 and ATF3 mRNA levels returned to control 
levels after 14 days (Fig. 25).  Pattern and levels of mRNA expression detected between 
axotomized and nerve crushed mice were found to be similar and therefore allowed us to 
continue our analysis of the anatomical consequences of Sox11 inhibition after nerve crush.  
Interestingly, we were able to maintain a knockdown of Sox11 and ATF3 for seven days when 













Fig. 25: Fold change in ATF3 and Sox11 mRNA at three, seven and 14 days after saphenous 
nerve crush and injection of either control (PenCON) or Sox11 targeting (PenSOX) siRNAs.  
After three days, PenCON injection plus nerve crush induces a 3.6-fold increase in Sox11 and a 
28.9-fold increase in ATF3.  PenSOX injection plus crushing the saphenous nerve only induces 
an increase in Sox11 mRNA to 2.36-fold and ATF3 16.1-fold relative to the contralateral side.  
Seven days after nerve crush, PenCON injected mice have a 3.9-fold increase in Sox11 and a 
16.1-fold increase in ATF3.  Injection of PenSOX siRNAs prior to nerve crush only permitted a 
2.6-fold increase in Sox11 and a 13.1-fold increase in ATF3.  After 14 days however, both 
PenCON and PenSOX injected mice showed similar levels of Sox11 and ATF3 expression 
(Sox11: 1.4-fold increase vs 1.57-fold increase; ATF3: 4.37-fold increase vs. 5.63-fold increase, 
respectively).    
 
 98 
 To determine if in vivo delivery of Sox11 siRNAs to the saphenous nerve blocked 
regeneration from nerve crush, we analyzed saphenous nerve regeneration in mice that received 
PenCON or PenSOX siRNA injection prior to a nerve crush.  The saphenous nerve is comprised 
of both myelinated and unmyelinated axons (Fig. 26A).  EM analysis of saphenous nerves at the 
injection site and crush site three days after nerve crush shows that injection of siRNAs into the 
nerve induces some damage to both myelinated and unmyelinated fibers (Fig. 26B).  However, 
crushing the saphenous nerve causes complete damage to all fibers (Fig. 26C).  Occasionally, 
some regenerating heavily myelinated fibers are present 1mm distal to the crush, but most fibers 
have not yet begun to regenerate at this time point in either PenCON or PenSOX injected 
conditions (Fig 27).   
  
 We therefore waited for mice to recover from saphenous nerve injury for one week after 
injection of siRNAs and nerve crush to analyze regeneration.  At 2 mm distal to the site of the 
nerve crush both regenerating myelinated and unmyelinated fibers were identified.  In Sox11 
siRNA injected nerves, several myelinated fibers were present though appeared smaller and less 
myelinated than in PenCON injected mice.  Unmyelinated fibers were also visible in Remak 
bundles.    Animals that received PenSOX siRNAs prior to nerve crush also displayed similar 
regeneration patterns.  Both myelinated and unmyelinated fibers were present 2mm distal to the 
nerve crush (not shown).  Initial quantification of regeneration 2mm distal to the nerve crush 






Fig. 26: Electron micrographs of the saphenous nerve at the site of siRNA injection, the site of 
nerve crush and under normal conditions.  A: Uninjured saphenous nerves have multiple 
myelineated (arrow) and unmyelinated (arrowheads) fibers.  B: Injection of siRNAs into the 
saphenous nerve induces some damage to myelinated (dashed arrow) and unmyelinated fibers.  
The majority of myelinated axons however appear normal (arrows) and unmyelinated fibers are 
still packaged into Remak bundles (arrowheads).  C: Crushing the saphenous nerve damages all 
fibers.  Myelinated fibers have degenerated and myelin sheaths have unraveled (dashed arrow).  
Remak bundles are largely disrupted and appear to be undergoing degeneration (arrowhead). 










Fig. 27: Electron micrographs of the saphenous nerve 1mm distal to the nerve crush three days 
after injury.  Extensive degeneration is present in saphenous nerves and most myelinated fibers 
are absent and show unraveling of their myelin (dashed arrows) in both control siRNA injected 
(Panel A) and Sox11 targeting siRNA injected mice (Panel B).  Occasionally, some myelinated 
fibers appeared to have begun regeneration (arrow).  Scale Bar: 2µm. 
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difference in the numbers of myelinated or unmyelinated axons (not shown).  We therefore 
analyzed regeneration 4mm distal to the nerve crush.  Several myelinated and unmyelinated 
fibers were present 4mm distal to the crush in PenCON injected mice (Fig. 28A); however, there 
was a significant reduction in the number of myelinated and unmyelinated fibers that regenerated 
4mm distal to the nerve crush in PenSOX injected mice (Figs. 28B).   Sox11 targeted siRNA 
injection decreased the number of myelinated fibers that had regenerated by 36% and the number 
of unmyelinated fibers that had regenerated by 51% (Fig. 29).  14d after nerve crush when Sox11 
and ATF3 mRNA levels begin to return to baseline, both PenCON and PenSOX injected mice 
showed similar extent of regeneration at the most distal segment (6mm) from the nerve crush 


















Fig. 28: Electron micrographs of the saphenous nerve 4mm distal to the nerve crush seven days 
after injury.  Panel A: Control siRNA (PenCON) injected mice show extensive regeneration of 
myelinated (arrow) and unmyelinated (arrowheads) axons.  Panel B: Sox11 targeting siRNA 
(PenSOX) injected mice show some regeneration of myelinated fibers (arrow) but fewer 












Fig. 29: Quantification of saphenous nerve regeneration in mice that underwent nerve crush and 
injection of either control (PenCON) or Sox11 targeting (PenSOX) siRNAs.  There was a 
significant difference in the number of regenerating myelinated fibers detected between PenCON 
(310 +/- 17) and PenSOX (198 +/- 14) injected mice (p value < 0.02).  There was also a 
significant difference in the number of regenerating unmyelinated fibers.  PenSOX injection 
reduced the number of unmyelinated axons that had regenerated 4mm distal to the nerve crush 
from 1267 +/- 26 to 622 +/- 43 (p value < 0.001).  Overall there was a 48% decrease in the 
number of fibers that regenerated 4mm in PenSOX siRNA injected mice compared to PenCON 











Fig. 30:  Electron micrographs of the saphenous nerve 6mm distal to the nerve crush 14 days 
after injury.  Both non-targeting siRNA injected (PenCON, panel A) and Sox11 targeting siRNA 
injected (PenSOX; panel B) mice show similar patterns of regeneration of both myelinated 
(arrows) and unmyelinated fibers (arrowheads).  There still is evidence of degeneration in some 




We have used a new approach to deliver siRNAs to peripheral nerves that allows the 
knockdown of gene expression in vivo.  Nerve injection of Penetratin-linked siRNAs allowed us 
to target cutaneous neurons that innervate the leg and foot specifically.  Injected siRNAs were 
taken up by axons and retrogradely transported back to the soma where they produced 
knockdown in gene expression.  Since the successful performance of RNA interference in vivo is 
dependent on targeted and efficient delivery, this approach offers a powerful means by which to 
regulate gene expression in vivo.  In this study, detectable knockdown of Sox11 mRNA was 
achieved within three days after injection.  The effect of this knockdown in vivo was an 
inhibition of ATF3 expression and peripheral nerve regeneration.   
 
Using Neuro2A cells, Sox11 was shown to be necessary to prevent cells from entering an 
apoptotic death pathway as cells were induced to differentiate (Jankowski et al., 2006).  Whether 
a similar mechanism operates in primary DRGs lacking Sox11 (Jankowski et al., 2005, 2006; 
CHAPTER FOUR) and in DRG neurons in vivo after nerve injury is unclear.  No cell death was 
detected three days after saphenous nerve injury as measured by immunolabeling for activated 
caspase3 (not shown) in the L2/L3 DRGs of PenCON or PenSOX injected and axotomized mice. 
Thus, the effects of Sox11 siRNA knockdown does not produce the same effect of knockdown in 
cultured cells in vitro.  It is likely that the effect of Sox11 upregulation from axotomy initiated 
cell survival pathways prior to a functionally significant Sox11 knockdown, which could be 
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detected on the mRNA level by day three.  The knockdown obtained in Sox11 mRNA was also 
transient in the injected and axotomized mice (Sox11 mRNA was inhibited for less than five days 
post axotomy; Fig. 24), in which case we may have been able to see casp3* immunostaining if 
we were able to knockdown expression for an extended period.  Performing activated caspase3 
labeling experiments in the L2/L3 DRGs of animals that receive PenSOX injection and nerve 
crush may allow us to detect neuroprotective affects of Sox11 after injury since some studies 
have reported cell death in injured DRG neurons only after at least a week (Jiang et al., 2005; 
Kuo et al., 2005; Thippeswamy et al., 2001).  However, since it is known that Sox11 can regulate 
cell death at early stages of cell differentiation (Jankowski et al., 2006), it seems likely that 
Sox11 is acting in a neuroprotective manner early after injury.  Intrathecal delivery of PenSOX 
siRNAs prior to nerve injury, which would allow us to induce a faster knockdown, may have 
enabled us to discover apoptotic cells in nerve injured mice within this time frame.   
5.4.1 Sox11 is enhanced by axotomy and necessary for the induction of ATF3 after injury. 
The increase in Sox11 mRNA after peripheral axotomy of the sciatic nerve has been 
reported previously (Jankowski et al., 2004; Tanabe et al., 2003).  In this study, we show that a 
similar pattern of Sox11 expression occurs in response to saphenous nerve crush and axotomy.  
The rise of Sox11 mRNA expression coincides with the time in which injured nerves are 
initiating Wallerian degeneration, “dying back” and subsequent regeneration (Baba et al., 1982; 
Kury et al., 2001; Mi et al., 2005; Sebille, 1982; Thomas, 1982).  It is also known that functional 
regeneration of the saphenous nerve occurs four weeks after nerve transection (McIlwrath et al., 
2005) and the levels of Sox11 mRNA have returned to baseline by this time.  Since we have 
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shown previously that Sox11 is required for proper neurite growth of DRG neurons in vitro, this 
in vivo evidence would suggest that Sox11 plays a role in functional nerve regeneration.   
 
Because Sox11 was shown in vitro to modulate ATF3 expression, we examined if ATF3 
expression could be regulated by Sox11 in vivo.  In animals whose peripheral nerve was injected 
with PenSOX siRNAs and then crushed or axotomized, ATF3 expression was inhibited relative 
to injection of control siRNA.  This knockdown in ATF3 does not appear to be due to an off-
target effect of the Sox11 siRNAs since the PenSOX siRNA sequence has almost no homology 
to the ATF3 gene.  Furthermore, we have shown previously that siRNA-mediated knockdown of 
Sox11 does not affect the levels of other transcription factors with higher sequence homology 
(Chapter Three, Fig. 4).  In addition, preliminary studies using luciferase reporter assays indicate 
a direct regulation of Sox11 on the ATF3 promoter (Kathleen Solerno, personal communication).   
ATF3 has been linked to neurite outgrowth (Seijfers et al., 2006) and nerve regeneration 
(Campbell et al., 2003; Isacsson et al., 2005; Lindwall et al., 2004) and many act through c-jun 
(Lindwall et al., 2004; Pearson et al., 2003).  Our data suggests that the role that Sox11 plays in 
nerve regeneration may therefore be, in part, via upstream regulatory action on ATF3 expression.   
5.4.2 Sox11 upregulation after nerve injury is essential for proper peripheral nerve 
regeneration.   
We have shown that inhibition of Sox11 significantly blocks the number of fibers that 
regenerate after crushing the saphenous nerve.  The functional affect of inhibition could not be 
quantified within three days of the crush but Sox11 inhibition does become significant after 
seven days.  Transfection of primary DRG neurons with PenSOX siRNAs reduces neurite 
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growth in all cell sizes (Chapter Four).  This correlates with nerve regeneration in vivo since both 
myelinated and unmyelinated fibers were affected by Sox11 inhibition.  Light microscopic 
analysis suggests that there is an equal uptake and retrograde transport of siRNAs in all fibers 
(Fig. 22); however, a detailed quantification of this feature would be necessary to rule out 
differential uptake of siRNAs among different fiber types.  Sox11 inhibition affected 
unmyelinated axon regeneration more than the myelinated axons.  This may be related to the fact 
that myelinated fibers regenerate faster than unmyelinated fibers (Lozeron et al. 2004).   In 
addition, it is possible that Sox11 inhibition more significantly hindered myelinated fiber 
regeneration prior to seven days and this was not measured.  Additional studies to analyze 
regeneration in PenCON and PenSOX injected mice between three and seven days after nerve 
crush will be necessary to determine the degree to which Sox11 regulates early myelinated fiber 
regeneration.   
 
Taking into consideration the in vitro evidence presented previously, it is possible that 
Sox11 plays a role in proper functional regeneration of nerves as well.  Branching indices of 
DRG neurons in vitro are greatly compromised by lack of sufficient levels of Sox11.  After 
saphenous nerves regenerate to the skin, it is reasonable to suggest that these axons will not be 
heavily branched in their peripheral targets.  A detailed analysis of axon arborzation in the skin 
after nerve regeneration in PenCON and PenSOX injected mice that underwent axotomy of the 
saphenous nerve will be necessary to test this hypothesis.  Nevertheless, we have shown that 
developmentally regulated transcription factor Sox11 is necessary for proper in vivo nerve 
regeneration, most likely through its regulatory actions on ATF3. 
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6.0  GENERAL DISCUSSION 
Individual populations of DRG neurons display unique protein expression patterns that 
contribute to their anatomical and functional properties.  During development, many DRG 
neurons express trkB and trkC receptors at embryonic day 10.5 (E10.5).  By E11.5, trkA 
becomes detectable and soon after becomes the most prevalent neurotrophin receptor present in 
the ganglion.  At approximately E13, the GDNF co-receptor, ret is upregulated, and later during 
embryogenesis, the GDNF family receptors (GFRs) are upregulated. Throughout this time, the 
level of each of the neurotrophins in the skin is changing and this in turn regulates the survival 
and differentiation of particular populations of sensory neurons (Huang et al. 1999).  Presence of 
neurotrophins and responsiveness of certain neurons to different neurotrophins are requisite for 
cell survival during the period of rapid cell death in the DRG (Oppenheim, 1991).  In fact, 
overexpression of different neurotrophins in the periphery can enhance the survival of different 
populations of sensory neurons.  Overproduction of NGF in the skin causes an increase in the 
survival of trkA positive neurons (Albers, 1994; 1996) while overexpression of GDNF results in 
the survival of the IB4 population of neurons (Zwick et al. 2002).  Furthermore, excess 
neurotrophin in the skin results in enhanced branching in the target tissue (Albers et al., 1994; 
LeMaster et al., 1995; Zwick et al., 2002).  This supports the hypothesis that neurotrophins are 
necessary for sensory neuron survival (Oppenheim, 1991) and for differentiation of different 
types of neurons (Lewin et al., 1992).  Peripheral projections become more elaborate and 
developed as neurons survive the period of programmed cell death (Berg and Farel, 2000).  
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However, the molecular mechanism that underlies how neurotrophic growth factors regulate 
survival and differentiation remains to be fully elucidated.   
 
Preliminary data suggested that overexpresion of NGF could enhance the survival of 
trkA/ CGRP neurons at the expense of the IB4 population.  Conversely, overproduction of 
GDNF in the skin resulted in a selective survival of ret and IB4 (Zwick et al. 2002) positive 
neurons while decreasing the expression of trkA in the trigeminal ganglia (TG). This may 
suggest that phenotypic expression is dependent on the neurotrophic responsiveness while 
survival may be dependent on common factors that can be activated by all neurotrophins.  The 
degree to which the neurotrophins can activate this mechanism may determine the level of 
survival.  In order to determine what factors may be regulating this phenomenon we performed 
microarray analysis on E16.5 and adult TGs from wild type, GDNF- and NGF-overexpressor 
transgenic mice (OEs).  This analysis revealed that many families of genes are differentially 
regulated in the sensory ganglia as a result of overproduction of neurotrophins in the periphery.  
Certain families of genes are likely candidates to regulate a common survival pathway from a 
wide range of signaling molecules.   
 
Microarray data from DRG and trigeminal neurons suggested that one transcription factor 
regulated by neurotrophic factor production in the skin was Sox11.  Sox11 is an HMG 
transcription factor thought to be associated with neuronal maturation due to its localization in 
sensory ganglia and the fact that it is upregulated during development (Hargrave et al., 1997; 
Uwanogho et al., 1995).  Overexpression of both NGF and GDNF resulted in enhanced levels of 
Sox11 in the trigeminal ganglia at E16.5 as verified by RT-PCR.  It was further determined that 
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Sox11 was localized to the neurons during development, and although not readily detectable in 
the adult DRG using immunocytochemistry, was significantly upregulated after peripheral nerve 
transection for several weeks.  The change in expression was found to be specific to the sensory 
ganglia as no change in Sox11 was found in the spinal cord dorsal horn after sciatic nerve 
axotomy (not shown).  The HMG superfamily of DNA-binding proteins can either activate or 
repress transcription of target genes and regulate multiple processes (Kamachi et al., 1999).  
Therefore, based on these data, the transcription factor Sox11 was chosen for further analysis to 
determine whether it had a role in regulating neuronal survival and differentiation and if it played 
a role in an animal’s response to injury in the adult. 
 
Initial studies using a neuroblastoma cell line showed that Sox11 increases as Neuro2A 
cells differentiate in vitro.  Upon addition of RA to the cultures, Neuro2A cells cease dividing 
and begin to extend neurites and undergo differentiation (Shea et al., 1984).  Sox11 is increased 
100% by addition of RA to Neuro2A cells suggesting that the increase in Sox11 may underlie in 
part, Neuro2A differentiation in response to RA.  To test this hypothesis, cells were transfected 
with siRNAs directed against Sox11 in the presence or absence of RA.  Sox11 siRNAs alone 
appear to have no affect on Neuro2A survival or differentiation; however, it is unclear if 
inhibition of Sox11 is blocking cell division since fewer cells were present after addition of 
Sox11 siRNAs.  Future studies will be necessary to determine if Sox11 plays a role in exiting the 
cell cycle.  Surprisingly, after addition of RA, Sox11 siRNAs induced significant cell death 
suggesting that Sox11 may be necessary for survival when cells are undergoing differentiation.  
The percentage of cells that normally differentiate in the presence of RA is similar to the 
percentage of cells that undergo programmed cell death in the presence of RA and Sox11 
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siRNAs.  Normal Sox11 function may be to promote neurite outgrowth as both untreated cells 
and RA treated cells both enhance their levels of Sox11 in correlation with the extent of 
differentiation/ neurite growth.  The fact that Neuro2A cells undergo apoptosis when sufficient 
levels of Sox11 are not attained as they differentiate suggests that Sox11 may have a dual role, 
supporting neurite growth and differentiation.  All of the aforementioned phenomena occur 
within 24h.  This would suggest that Sox11 is highly important for the early stages of 
differentiation and lack of this transcription factor during this critical period results in apoptosis.   
 
To investigate how Sox11 functions, microarray screening of genes linked to the 
apoptosis pathway were used to analyze changes in gene expression in Neuro2A cells grown 
with RA and transfected with or without Sox11 siRNAs. Multiple genes were differentially 
regulated by inhibition of Sox11.  We focused our analysis on genes that contained Sox11 
binding sites in their upstream promoter regions.  Two survival related genes, BNIP3 and TANK 
were found to be increased and decreased respectively by lack of Sox11 in RA treated cells.  
Cells transfected with BNIP3 have been shown to rapidly undergo apoptosis (Chen et al., 1999) 
and TANK has been linked to enhanced proliferation (Conti et al., 2005) and stress responses 
(Chin et al., 1999; Coyle et al., 2003).  An increase in a pro-apoptosis gene such as BNIP3 in 
conjunction with downregulation of a survival/ stress activated gene like TANK may underlie 
how Sox11 is mediating its affects on cell death.   Although it is unclear at this time if Sox11 is 
directly binding to the promoters of these genes and regulating their transcription, lack of Sox11 
does alter the mRNA levels of these genes, which may in turn result in the induction of apoptosis 
seen in Neuro2A cells treated with RA and Sox11 siRNAs.  
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The experiments performed thus far suggest that Sox11 may play a role in neuron 
survival and differentiation; however, it is not clear if this gene has functional significance in 
peripheral sensory neurons specifically and whether similar features could be detected in the 
adult after peripheral nerve injury.  Totest this, we used adult mouse dissociated DRG neurons to 
analyze Sox11 function.  Although another way to analyze Sox11 function in sensory neurons 
would have been to use a knockout strategy, these mice exhibit early postnatal death (Sock et al., 
2001).  Assay of Sox11 expression in cultured DRG neurons showed however a very similar 
significant upregulation in Sox11 following plating.  Thus it allowed us to use primary cultures 
to study the importance of Sox11 expression following axotomy.   
 
Transfection of adult neurons can be problematic when designing in vitro experiments.  
On average, adult neurons are only transfected at an efficiency of 1%.  Performing experiments 
on an entire neuron culture thus would be severely confounded when using this method.  
Lipophillic reagents can greatly enhance the ability of adult cells to be transfected, but have been 
shown to induce cell death (Davidson et al., 2000).  Therefore to both mimick studies performed 
in Neuro2A cells and use adult primary DRG neurons, we modified the siRNAs against Sox11 
with Penetratin-1.  Penetratin-1 has been shown to be a highly lipophillic protein that is able to 
cross cell membranes (Derossi et al., 1998) and when conjugated to siRNAs via a disulfide bond, 
can greatly enhance the transfection efficiency of adult primary neurons without inducing cell 
death and without inhibiting the function of the siRNAs (Davidson et al., 2000).   
 
siRNA knockdown of Sox11 mRNA in adult DRG neurons in vitro was transient but 
significant and induced a protein knockdown that lasted for several days.  Quantification of cell 
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death in these neurons showed that there was a 2-fold increase in casp3* positive neurons at 24h 
and 4d in vitro.   This correlated with what was shown in Neuro2A cells induced to differentiate 
with RA without sufficient levels of Sox11 suggesting that similar functions of Sox11 found in 
Neuro2A cells relating to apoptosis may also be present in injured DRG neurons.  Since the 
majority of adult DRG neurons do not readily undergo programmed cell death from a peripheral 
axotomy (Jiang et al., 2005; Kuo et al., 2005), the function of Sox11 upregulation after nerve 
injury may be to initiate neuroprotective and anti-apoptotic mechanisms.  Genetic screens of 
programmed cell death-related genes in primary DRGs transfected with Sox11 siRNAs shows 
that many apoptosis associated genes are regulated in the absence of Sox11.  TANK was again 
found to be regulated by Sox11 in primary DRGs along with other apoptosis inducing factors 
such as Traf1.  Thus, Sox11 may indeed be protecting sensory neurons from injury induced cell 
death. 
 
Another feature of RA treated Neuro2A cells was that neurite branching and 
differentiation correlated with an increase in Sox11.  Evidence in adult DRG neurons shows that 
as neurons grow in vitro into intricate neuronal networks, Sox11 is subsequently upregulated.  
We therefore wanted to investigate whether Sox11 also played a role in neurite growth.  
Quantification of neurite growth and branching in DRG neurons shows that there is a gradual but 
significant increase in neurite length over time as well as an increase in branching.  Inhibition of 
Sox11 not only inhibited branching for several days, but it also blocked the normal increase in 
neurite length.  All populations of DRG neurons appeared to be affected (albeit to different 
degrees) by Sox11 inhibition.  These data imply that along with a potential neuroprotective 
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function of Sox11, this transcription factor may also be important for neurite growth and nerve 
regeneration of adult sensory axons. 
 
To determine if experiments designed to analyze the role of Sox11 in nerve regeneration 
were reasonable, we first performed RT-PCR on numerous neurite growth and regeneration 
associated genes in primary DRG neurons transfected with Sox11 siRNAs.  Inhibition of Sox11 
significantly altered the expression of growth associated genes ATF3, Arpc3 and Sprr1a.  ATF3 
is a classic marker of injured neurons and has been linked to neurite ourtgrowth and nerve 
regeneration (Seijfers et al., 2006; Lindwall et al., 2004; Issacson et al., 2005; Tsujino et al., 
2000).  Arpc3 is not characterized as well as ATF3, but is known to be important for actin 
cytoskelatal stability (Beltzner and Pollard, 2004; Zhang et al., 2005).  Sprr1a has been identified 
as a gene that is upregulated by nerve injury and important for nerve regeneration and axon 
elongation (Bonilla et al., 2002).  These results suggest that Sox11 may be mediating its actions 
on neurite growth by regulating these pro-axon growth genes.  Although luciferase assays would 
be necessary to confirm a direct promoter regulation of these genes by Sox11, multiple Sox11 
binding sites in the promoter regions of these genes suggests that Sox11 has the potential for 
direct regulation.  The fact that Sox11 can regulate the expression of more than one gene linked 
to the axon growth pathway, allows one to speculate that this transcription factor may be a 
master regulator of axon regeneration in the adult after nerve damage.  Previous work on other 
Sox genes like Sox10 have shown that these transcription factors bind to DNA tightly and make 
it sterically feasible for other transcription factors to bind nearby.  This feature of the ability of 
Sox genes to enhance the affinity of other DNA binding proteins for DNA may increase the 
specificity as well as diversity of Sox gene function (Schlierf et al., 2002; Wegner, 1999). 
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These results promoted us to investigate whether Sox11 was functionally relevant in adult 
sensory neurons after injury in vivo.  We therefore, analyzed the extent of nerve regeneration and 
expression of one neurite growth/ regeneration associated gene, ATF3, after a nerve crush in the 
presence or absence of Sox11.  In order to perform this type of analysis, we needed to determine 
how to deliver siRNAs directly to the cells in the DRGs that would be injured.  Peri-DRG or 
intrathecal delivery is known to deliver siRNAs successfully to the ganglia; however, not all 
axons that make up a nerve originate in a single ganglion.  We therefore attempted to knockdown 
Sox11 expression by directly injecting the Penetratin-1 conjugated siRNAs into the saphenous 
nerve and allowed them to retrogradely transport back to the somas that make up that nerve.  
This is a previously uncharacterized method of siRNA delivery to neurons but has proven to be a 
successful and efficient way to analyze gene function in vivo specifically in neurons that make 
up a single nerve.  Our data shows that not only do we obtain a knockdown in Sox11 mRNA in 
vivo, but we also knock down the expression of ATF3, similar to what we have shown in vitro.   
We therefore proceeded with anatomical analysis of regenerating nerves at the electron 
microscopic level.  No change in the rate of regeneration could be detected three days after nerve 
crush.  This is not surprising since peripheral nerves undergo a period of “dying back” and 
initiation of Wallerian degeneration during the first several days after nerve transection or crush 
(Baba et al., 1982; Mi et al., 2005; Sebille, 1982; Thomas, 1982).  The degenerating myelin and 
nerves need to be cleaned of debris by infiltrating macrophages and prepared for regeneration.  
Seven days after nerve crush however, control injected mice show extensive regeneration 4mm 
distal to the nerve crush.  Inhibition of Sox11 resulted in a decrease in the number of myelinated 
and unmyelinated regenerating saphenous nerve fibers that reached the 4mm distance; a 
phenomenon that subsides when Sox11 mRNA levels return to control levels after 14 days.  In 
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vivo inhibition of Sox11 results in a decrease in ATF3 expression and blockade of nerve 
regeneration supporting the hypothesis that Sox11 is a transcription factor that is responsible for 
inducing pro-regeneration genes necessary for proper nerve regeneration.     
 
This report is the first evidence that HMG-box transcription factor Sox11 is necessary for 
peripheral nerve regeneration.  Sox11 may be necessary to activate genes associated with 
regeneration while repressing those involved in apoptosis.  It will be important in the future to 
determine how Sox11 itself is upregulated in response to nerve injury.  Studies have shown that 
during development, Sox11 is upregulated in response to neurotrophins NGF and GDNF 
(Jankowski et al., 2004).  Evidence in adult primary DRG neurons shows that within the first 24h 
in vitro, the presence of NGF actually inhibits the upregulation of Sox11 mRNA.  However, after 
five days in vitro, NGF enhances the levels of Sox11 (Fig 31).  It is tempting to speculate that the 
neurotrophins have a dual function after injury; one that initially is inhibitory to pro-regeneration 
genes followed by a period of axon growth promotion.  This is plausible since delivery of NGF 
or GDNF to the DRG neurons before nerve transection reduces the expression of ATF3 (Averill 











Fig. 31: Fold Change in Sox11 mRNA after one day and five days in vitro in the presence or 
absence of NGF.  Sox11 mRNA normally increases 5.6-fold after one day and falls to 3.3-fold 
after five days (blue bars; NGF-).  The presence of NGF prevents the initial increase in Sox11 
expression (2.92-fold increase) but induces more Sox11 mRNA expression after five days in 
vitro (5.8-fold increase) relative to cells grown without NGF (red bars; NGF+). * p value < 0.05; 






neurons from their peripheral source of neurotrophins and replenishing this source prior to 
axotomy prevents normal upregulation of injury markers and pro-regeneration genes like ATF3.   
Our in vitro evidence supports this hypothesis since NGF can inhibit Sox11 expression at 24h.  
However, neurotrophins are known to be upregulated in the targets of sensory neurons after 
various peripheral injuries (Ji et al., 2003; Jin et al., 2002) and at the site of injury in support 
cells (Omura et al., 2005; Lee et al., 2001; Syroid et al., 2000) after 48h (Zhou et al., 1999).  
These data suggest that an upregulation of peripheral neurotrophins after injury serves to prepare 
the regenerating axons for re-innervation or to induce survival promoting mechanisms and 
programs of axon growth maintenance.  The timing of the different effects of neurotrophins after 
axotomy also suggests that neurotrophins could have a dual function.  So it is reasonable to 
suggest that peripheral axotomy induces the expression of pro-survival and pro-regeneration 
genes like Sox11 and ATF3 and immediately replenishing the neurotrophic supply induces a 
pathway of signaling in the cells that prevents this upregulation.  However, after the initial 
upregulation of Sox11 and ATF3 has occurred, neurotrophins can be necessary for axon growth 
as shown during development (Arumae et al., 1993; Yan et al., 2003).  Maintenance of Sox11 
expression which we have shown is necessary for neurite growth and regeneration after the 
initial stage of nerve injury, may therefore involve neurotrophic signaling.   
 
The fact that Sox11 is differentially regulated by NGF at 24h and 5d in vitro suggests a 
dual function for the neurotrophic regulation of axon outgrowth.  Studies involving other Sox 
genes and signaling pathways have described phenomena similar to our data.  Bone 
morphogenetic protein (BMP) signaling in early stages of limb chondrogenesis is pro-apoptotic 
while expression of Sox8 and 9 are necessary for induction of chondrogenesis.  After the initial 
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stages of chondrogenesis, BMP signaling was found to be necessary for maintaining the 
expression and function of Sox9 (along with Sox5 and 6) in late stage chondrocyte 
differentiation (Chimal-Monroy et al., 2003).  Future studies designed to determine if the 
neurotrophins truly play two roles during injury responses and subsequent regeneration/ neurite 
growth will be necessary to establish these hypotheses. 
 
The downstream targets of the neurotrophins or upstream signaling pathways that may be 
responsible for changes in Sox11 are currently unknown.  Mitogen activated protein kinase 
(MAPK) p38 is activated at the site of injury within three minutes after nerve transection (Zrouri 
et al., 2004) and is one possible candidate for the upregulation of Sox11 after injury.  Sox11 also 
contains multiple protein kinase C (PKC) phosphorylation sites, and PKC is known to be 
upregulated after peripheral injury as well (Wiklund et al., 1996).  Understanding how Sox11 is 
regulated after injury, whether it is via neurotrophic signaling or some other means is an 
important question that needs to be addressed in the future to fully determine the functional 
significance of Sox11 after injury.  Future endeavors should include experiments to determine if 
MAPKs, protein kinases or neurotrophins are responsible for the upregulation of Sox11 after 
nerve regeneration to decipher the mechanism of Sox11 actions.   
 
DRG neurons are known to regenerate their peripheral axons but not their central axons 
(Snider et al., 2002) and it is known that certain transcriptional mechanisms are initiated after 
peripheral but not central nerve injury (Kenny and Koscis, 1997).  One example of a gene that is 
significantly increased after peripheral axotomy but not central axotomy is ATF3 (Seijfers et al., 
2006; Shortland et al., 2006).  We have suggested that Sox11 may be necessary for the 
 121 
upregulation of ATF3 after peripheral nerve injury; therefore, it is reasonable to hypothesize that 
Sox11 will not be altered as a result of central nerve injury.  Our data shows that L5 rhizotomy 
does not induce a significant increase in Sox11 in the L5 DRGs.  In fact, there is a significantly 
larger increase in Sox11 mRNA after sciatic nerve axotomy compared to L5 rhizotomy (Fig. 32).  
Since we have shown that Sox11 is necessary for proper neurite growth and saphenous nerve 
regeneration, possibly through its regulation of ATF3, is it reasonable to suggest that the lack of 
ATF3 from central injury is due to the lack of Sox11.  In this regard, Sox11 is a likely candidate 
gene to describe the transcriptional discrepancies that are present in DRG neurons between 
central and peripheral injuries.  A detailed analysis of the role of Sox11 after rhizotomy will be 
necessary to elucidate the function of Sox11 after central nerve injury and whether artificial 
induction of Sox11 after injuries of this kind enhances central axon regeneration of the dorsal 
columns.   
 
In conclusion, the data described herein suggests that the HMG transcription factor 
Sox11 is necessary for neuron survival and neurite growth after injury (Fig. 33).  Sox11 appears 
to be implementing its effects on survival and axon regeneration through regulation of genes 
linked to apoptosis and neurite growth.  Although the direct mechanism of how Sox11 itself is 













Fig. 32: Fold change in Sox11 mRNA after L5 rhizotomy and sciatic nerve axotomy.  Three days 
after L5 rhizotomy, there is only a small increase in Sox11 mRNA in the L5 DRGs relative to the 
contralateral ganglia.  Four days after sciatic nerve axotomy, there was a large increase in Sox11 
mRNA relative to the contralateral ganglia.  Axotomy was found to significantly increase the 
levels of Sox11 compared to rhizotomy (*p value < 0.001).     
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expression through neurotrophic signaling.  The molecule(s) downstream of neurotrophin 
receptors and upstream of Sox11 remains to be determined.  Nevertheless, these studies are the 
first evidence that developmentally regulated transcription factor Sox11 can regulate two 
separate pathways of apoptosis and neurite growth (and possibly other pathways linked to the 
general injury response) is induced after peripheral nerve injury in the adult.  These experiments 
may provide evidence to develop new therapies for patients that experience poor nerve 
regeneration or receovery following nerve injury. These data may also provide insight to the 
differences that arise between peripheral and central nerve injuries and whether genes like Sox11 










Fig. 33: Summary diagram of the sox11 regulation of the injury response.  Injury to sensory 
neurons in conjunction with both positive and negative neurotrophic signaling (through an 
undetermined factor) results in a balanced increase in Sox11 expression.  The Sox11 
transcription factor then has the function of turning off the transcription of pro-death genes like 
BNIP3 while it promotes the transcription of pro-survival genes like TANK and pro-regeneration 
genes like ATF3 and Arpc3.  The overall effect of enhanced levels of Sox11 in response to nerve 
injury is to promote neurite growth and regeneration while inhibiting apoptosis.   
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APPENDIX A: ADDITIONAL INFORMATION 
 
Sox11 may also have an uncharacterized role in the general injury response or injury 
induced pain states.  Sox11 regulates the expression of many genes known to be associated with 
nerve injuries and inflammation (Fig. 34; Molliver et al. 2005; Costigan et al., 2002) and thus 
may underlie the means to which changes in gene expression are associated with peripheral 
inflammation, nerve transection or pain in general.  RT-PCR analysis of 12 genes linked to 
peripheral inflammation revealed that seven of them were differentially regulated by 
overexpresion of Sox11.  N-methyl-d aspartate (NMDA) receptor subunits NR1 and NR2 are 
both changed in the DRGs after injection of complete Freund’s adjuvant (CFA) into the hindpaw 
(Molliver et al., 2005; Wang et al., 1999).  Transfection of Neuro2A cells with a plasmid vector 
containing Sox11 driven by a CMV promoter shows that there is a decrease in NR1 and an 
increase in NR2 receptor subunit expression similar to what has been shown in vivo after CFA 
injection.  We also found that receptors mGluR1, mGluR5 and GFRα1 which have been linked 
to sensory neuron sensitivity (Huang et al., 2005; Crawford et al., 2000; Pollock et al., 1999; 
Bennett et al., 2000) were also altered as a result of enhanced Sox11 expression.  Transfected 
Neuro2A cells also show that transient receptor potential vanilloid 1 (TrpV1) and TrpV2 were 
downregulated 24h after transfection.  TrpV1 has been linked to noxious heat responses in mice 
(Caterina et al., 1997) and is known to be upregulated in response to inflammation in the DRGs 
(Bar et al., 2004; Ji et al., 2002; Molliver et al., 2005; Wilson-Gerwing et al., 2005) but 
downregulated by axotomy (Michael and Priestley, 1999).  TrpV2 displays similar features after 












Fig. 34: Alternate changes in gene expression in Neuro2A cells transfected with plasmid vectors 
containing Sox11 and an eGFP reporter.  Many genes linked to neuronal sensitivity are altered 
by enhanced levels of Sox11.  Transient receptor potential vanilloid receptor 1 (TrpV1), TrpV2, 
the NR1 subunit of the N-methyl-d-aspartate (NMDA) receptor, metabotropic glutamate receptor 
1 (mGluR1) and mGluR5 are all decreased by overproduction of Sox11.  The NR2 subunit of the 
NMDA receptor and GDNF-family receptor α1 (GFRα1) are both increased by Sox11 
overexpression.   
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axotomy (Gaudet et al., 2004).    Thus Sox11 may also play a role in neuronal sensitivity or 
responses to inflammation. 
 
To test whether Sox11 was regulated by inflammation, pilot studies were performed on 
wild type (WT), GDNF-OE and NGF-OE DRGs at multiple time points after injection of CFA 
into the hindpaw.  Surprisingly, Sox11 was regulated to a small degree by peripheral 
inflammation.  GDNF-OEs showed a larger increase in Sox11 four days after CFA injection than 
WT mice (Fig. 35); however, NGF-OEs not only had a lower baseline level of Sox11 in the 
DRGs, but Sox11 was not altered at any time point after injection of CFA.  The results are 
intriguing since both NGF- and GDNF-OEs have increased numbers of nociceptors (Albers et 
al., 1994; Zwick et al., 2002).  It will be interesting to investigate in the future whether the 
changes in gene expression that are induced by overexpression of Sox11 in vitro result in the 














Fig. 35: Fold change in Sox11 mRNA in the L4/L5 DRGs after injection of complete freund’s 
adjuvant (CFA) into the hindpaw of wildtype (WT), GDNF overexpressing (GDNF-OE) and 
NGF-overexpressing (NGF-OE) mice.  CFA injection induces a small increase in the DRGs of 
WT mice that peaks four days after injection (1.85-fold increase) and returns to baseline after 
two weeks. GDNF-OEs show a similar pattern but the peak level of expression at four days 
shows a 3.6-fold increase.  Surprisingly, NGF-OEs did not display an increase in Sox11 
expression after injection of CFA into the hindpaw.  In fact, NGF-OEs have a lower baseline 
level of Sox11 relative to their WT littermates (1.56-fold decrease).   
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APPENDIX B: LIST OF ABBREVIATIONS 
 
ABC- avidin biotin peroxidase 
Arpc3- actin related protein complex subunit 3 
ATF3- activating transcription factor 3 
Bad- Bcl-associated death promoter 
Bax- Bcl-2 associated x protein 
Bcl10- B-cell lymphoma-like 10 
Bcl2- B-cell lymphoma-like 2 
Bcl2a1d- Bcl2 associated protein 1d 
Bcl2l10- Bcl-2-like 10 
BDNF- brain derived neurotrophic factor 
BI- branching index 
Bid- BH3- interacting domain death agonist 
Biklk- Bcl-2 interacting killer like 
Birc6- Baculoviral IAP repeat-containing 6 
Blk- B lymphoid kinase 
BMP- bone morphogenetic protein 
BNIP3- Bcl2 interacting protein NIP3 
Bok- Bcl-2 related ovarian killer protein 
BrdU- bromodeoxyuridine 
Casp- caspase 
Casp2- caspase 2 
Casp3*- activated caspase 3 
Casp8ap2- caspase 8 associated protein 2 
Casp9- caspase 9 
CFA- complete Freund’s adjuvant 
CGRP- calcitonin gene related peptide 
CMV- cytomegalovirus 
CNS- central nervous system 
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DAB- 3, 3-diaminobenzidine 
DAPI- 4, 6-diamino-2-phenyl-indole, dihydrochloride 
DIC- differential interference contrast 
DIV- days in vitro 
DRG- dorsal root ganglion 
DUSP6- dual specificity phosphatase 6 
EC- embryonic carcinoma 
EM- electron microscopy 
ERK- extracellular signal related kinase 
Fas- TNF receptor 
FGF- fibroblast growth factor 
GABA- gamma amino butyric acid 
GAPDH- glyceraldehyde-3-phosphate dehydrogenase 
GDNF- glial cell line derived neurotrophic factor 
GDNF-OE- GDNF overexpressor 
GFR- GDNF family receptor 
GPI- glycosyl phosphatidyl inositol 
HBSS- Hank’s balanced salt solution 
HMG- high mobility group 
IAP- inhibitor of apoptosis 
IB4- isolectin B4 
JNK- c-jun N-terminal kinase 
MAPK- mitogen activated protein kinase 
Mcl1- myeloid cell leukemia sequence 1 
MEM- minimal essential media 
MEMS- MEM containing fetal bovine serum 
MEMS-RA- MEMS containing 20µM RA 
mGluR- metabotropic glutamate receptor 
N52- neurofilament 200 
Neuro2A- neuroblastoma 2A 
NF- neurofilament 
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NFκB- nuclear factor κB 
NGF- nerve growth factor 
NGF-OE- NGF overexpressor 
NMDA- N-methyl-d-aspartate 
NSE- neuronal specific enolase 
NT-3- neurotrophin 3 
PBS- phosphate buffered saline 
PenCON/ Pen-siCON- Penetratin linked control siRNAs 
PenSOX/ Pen-siSOX- Penetratin linked Sox11 targeting siRNAs 
PGP- protein gene product 
PKC- protein kinase C 
PNS- peripheral nervous system 
PTPro- protein tyrosine phosphatase receptor type O 
RA- retinoic acid 
RAR- retinoic acid receptor A 
RISC- RNA induced silencing complex 
RNAi- RNA interference 
RT-PCR- reverse transcriptase polymerase chain reaction 
RT- room temperature 
RXR- retinoic acid receptor X 
SC- spinal cord 
siControl- non-targeting control siRNA 
siRNA- small interfering RNA 
Sox- SRY-box containing gene 
Sprr1a- small proline rich protein 1a 
SwC- Schwann cell 
TANK- Traf member- associated NfκB activator 
TG- trigeminal ganglion 
TNF- tumor necrosis factor 
Tnfrsf21- TNF receptor superfamily 21 
Trk- tyrosine receptor kinase 
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TrpV- transient receptor potential vanilloid 
TUNEL- terminal deoxynucleotidyl nick end labeling 
WD- Wallerian degeneration 
WT- wild type 
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